{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:55Z","timestamp":1793066335247,"version":"4.5.0"},"publisher-location":"Cham","reference-count":253,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031883606","type":"print"},{"value":"9783031883613","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-88361-3_11","type":"book-chapter","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T14:42:04Z","timestamp":1756478524000},"page":"245-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Muscular Dystrophies"],"prefix":"10.1007","author":[{"given":"Yi-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Bittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Bittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jae","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki M.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti K.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"issue":"6","key":"11_CR1","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41423-019-0331-0","volume":"18","author":"RA Adams","year":"2021","unstructured":"Adams RA, Fernandes-Cerqueira C, Notarnicola A, Mertsching E, Xu Z, Lo W-S, Ogilvie K, Chiang KP, Ampudia J, Rosengren S, Cubitt A, King DJ, Mendlein JD, Yang X-L, Nangle LA, Lundberg IE, Jakobsson P-J, Schimmel P (2021) Serum-circulating his-tRNA synthetase inhibits organ-targeted immune responses. Cell Mol Immunol 18(6):1463\u20131475. https:\/\/doi.org\/10.1038\/s41423-019-0331-0","journal-title":"Cell Mol Immunol"},{"issue":"15\u201316","key":"11_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1089\/hum.2022.069","volume":"33","author":"S Ait Benichou","year":"2022","unstructured":"Ait Benichou S, Jauvin D, De Serres-B\u00e9rard T, Bennett F, Rigo F, Gourdon G, Boutjdir M, Chahine M, Puymirat J (2022) Enhanced delivery of ligand-conjugated antisense oligonucleotides (C16-HA-ASO) targeting Dystrophia Myotonica protein kinase transcripts for the treatment of myotonic dystrophy type 1. Hum Gene Ther 33(15\u201316):810\u2013820. https:\/\/doi.org\/10.1089\/hum.2022.069","journal-title":"Hum Gene Ther"},{"issue":"28","key":"11_CR3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022960118","volume":"118","author":"Z Al Tanoury","year":"2021","unstructured":"Al Tanoury Z, Zimmerman JF, Rao J, Sieiro D, McNamara HM, Cherrier T, Rodr\u00edguez-delaRosa A, Hick-Colin A, Bousson F, Fugier-Schmucker C, Marchiano F, Habermann B, Chal J, Nesmith AP, Gapon S, Wagner E, Gupta VA, Bassel-Duby R, Olson EN et al (2021) Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell\u2013derived skeletal muscle in vitro. Proc Natl Acad Sci 118(28):e2022960118. https:\/\/doi.org\/10.1073\/pnas.2022960118","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"11_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/practneurol-2022-003429","volume":"22","author":"AL Alungulese","year":"2022","unstructured":"Alungulese AL, Garc\u00eda Soldevilla MA, Gordo Ma\u00f1as R, Vidal D\u00edaz MB (2022) Oculopharyngeal muscular dystrophy coexisting with myasthenia gravis. Pract Neurol 22(5):413\u2013414. https:\/\/doi.org\/10.1136\/practneurol-2022-003429","journal-title":"Pract Neurol"},{"issue":"3","key":"11_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1073\/pnas.0610270104","volume":"104","author":"A Angelin","year":"2007","unstructured":"Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C, Mattioli E, Gualandi F, Ferlini A, Merlini L, Maraldi NM, Bonaldo P, Bernardi P (2007) Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci 104(3):991\u2013996. https:\/\/doi.org\/10.1073\/pnas.0610270104","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"11_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.52.1.176","volume":"52","author":"C Angelini","year":"1999","unstructured":"Angelini C, Fanin M, Freda MP, Duggan DJ, Siciliano G, Hoffman EP (1999) The clinical spectrum of sarcoglycanopathies. Neurology 52(1):176\u2013176. https:\/\/doi.org\/10.1212\/WNL.52.1.176","journal-title":"Neurology"},{"key":"11_CR7","unstructured":"Annseau E (2007) Expression of the DUX4c gene located within a repeated element close to the FSHD locus"},{"issue":"10","key":"11_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007482","volume":"4","author":"E Ansseau","year":"2009","unstructured":"Ansseau E, Laoudj-Chenivesse D, Marcowycz A, Tassin A, Vanderplanck C, Sauvage S, Barro M, Mahieu I, Leroy A, Leclercq I, Mainfroid V, Figlewicz D, Mouly V, Butler-Browne G, Belayew A, Copp\u00e9e F (2009) DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One 4(10):e7482. https:\/\/doi.org\/10.1371\/journal.pone.0007482","journal-title":"PLoS One"},{"issue":"1","key":"11_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146893","volume":"11","author":"E Ansseau","year":"2016","unstructured":"Ansseau E, Eidahl JO, Lancelot C, Tassin A, Matteotti C, Yip C, Liu J, Leroy B, Hubeau C, Gerbaux C, Cloet S, Wauters A, Zorbo S, Meyer P, Pirson I, Laoudj-Chenivesse D, Wattiez R, Harper SQ, Belayew A, Copp\u00e9e F (2016) Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS One 11(1):e0146893. https:\/\/doi.org\/10.1371\/journal.pone.0146893","journal-title":"PLoS One"},{"issue":"3","key":"11_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/genes8030093","volume":"8","author":"E Ansseau","year":"2017","unstructured":"Ansseau E, Vanderplanck C, Wauters A, Harper S, Copp\u00e9e F, Belayew A (2017) Antisense oligonucleotides used to target the DUX4 mRNA as therapeutic approaches in FaciosScapuloHumeral muscular dystrophy (FSHD). Genes 8(3):93. https:\/\/doi.org\/10.3390\/genes8030093","journal-title":"Genes"},{"issue":"9","key":"11_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/hmg\/2.9.1397","volume":"2","author":"M Anvret","year":"1993","unstructured":"Anvret M, Ahlberg G, Grandell U, Hedberg B, Johnson K, Edstr\u014dm L (1993) Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum Mol Genet 2(9):1397\u20131400. https:\/\/doi.org\/10.1093\/hmg\/2.9.1397","journal-title":"Hum Mol Genet"},{"issue":"2","key":"11_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41551-021-00838-2","volume":"6","author":"L Arandel","year":"2022","unstructured":"Arandel L, Matloka M, Klein AF, Rau F, Sureau A, Ney M, Cordier A, Kondili M, Polay-Espinoza M, Naouar N, Ferry A, Lemaitre M, Begard S, Colin M, Lamarre C, Tran H, Bu\u00e9e L, Marie J, Sergeant N, Furling D (2022) Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nat Biomed Eng 6(2):207\u2013220. https:\/\/doi.org\/10.1038\/s41551-021-00838-2","journal-title":"Nat Biomed Eng"},{"issue":"6360","key":"11_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/355548a0","volume":"355","author":"C Aslanidis","year":"1992","unstructured":"Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, Chen C, Alleman J, Wormskamp NGM, Vooijs M, Buxton J, Johnson K, Smeets HJM, Lennon GG, Carrano AV, Korneluk RG, Wieringa B, De Jong PJ (1992) Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355(6360):548\u2013551. https:\/\/doi.org\/10.1038\/355548a0","journal-title":"Nature"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-61737-982-6_2","volume-title":"Muscle gene therapy","author":"T Athanasopoulos","year":"2011","unstructured":"Athanasopoulos T, Foster H, Foster K, Dickson G (2011) Codon optimization of the microdystrophin gene for Duchenne muscular dystrophy gene therapy. In: Duan D (ed) Muscle gene therapy, vol 709. Humana Press, pp 21\u201337. https:\/\/doi.org\/10.1007\/978-1-61737-982-6_2"},{"issue":"3","key":"11_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5582\/irdr.2016.01056","volume":"5","author":"B Bao","year":"2016","unstructured":"Bao B, Maruyama R, Yokota T (2016) Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy. Intractable Rare Dis Res 5(3):168\u2013176. https:\/\/doi.org\/10.5582\/irdr.2016.01056","journal-title":"Intractable Rare Dis Res"},{"issue":"3","key":"11_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ajhg.2017.01.033","volume":"100","author":"L Barb\u00e9","year":"2017","unstructured":"Barb\u00e9 L, Lanni S, L\u00f3pez-Castel A, Franck S, Spits C, Keymolen K, Seneca S, Tom\u00e9 S, Miron I, Letourneau J, Liang M, Choufani S, Weksberg R, Wilson MD, Sedlacek Z, Gagnon C, Musova Z, Chitayat D, Shannon P et al (2017) CpG methylation, a Parent-of-origin effect for maternal-biased transmission of congenital myotonic dystrophy. Am J Hum Genet 100(3):488\u2013505. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.033","journal-title":"Am J Hum Genet"},{"issue":"2","key":"11_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41551-020-00607-7","volume":"5","author":"R Batra","year":"2020","unstructured":"Batra R, Nelles DA, Roth DM, Krach F, Nutter CA, Tadokoro T, Thomas JD, Sznajder \u0141J, Blue SM, Gutierrez HL, Liu P, Aigner S, Platoshyn O, Miyanohara A, Marsala M, Swanson MS, Yeo GW (2020) The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1. Nat Biomed Eng 5(2):157\u2013168. https:\/\/doi.org\/10.1038\/s41551-020-00607-7","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"11_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0378-1119(00)00602-8","volume":"264","author":"M Beckers","year":"2001","unstructured":"Beckers M, Gabri\u00ebls J, van der Maarel S, De Vriese A, Frants RR, Collen D, Belayew A (2001) Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. Gene 264(1):51\u201357. https:\/\/doi.org\/10.1016\/s0378-1119(00)00602-8","journal-title":"Gene"},{"issue":"12","key":"11_CR19","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3748\/wjg.v12.i12.1821","volume":"12","author":"M Bellini","year":"2006","unstructured":"Bellini M (2006) Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol 12(12):1821. https:\/\/doi.org\/10.3748\/wjg.v12.i12.1821","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13023-019-1019-3","volume":"14","author":"A Ben Hamou","year":"2019","unstructured":"Ben Hamou A, Espiard S, Do Cao C, Ladsous M, Loyer C, Moerman A, Boury S, Kyheng M, Dhaenens C-M, Tiffreau V, Pigny P, Lebuffe G, Caiazzo R, Aubert S, Vantyghem MC (2019) Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance. Orphanet J Rare Dis 14(1):42. https:\/\/doi.org\/10.1186\/s13023-019-1019-3","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"11_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/mus.26176","volume":"58","author":"KN Berggren","year":"2018","unstructured":"Berggren KN, Hung M, Dixon MM, Bounsanga J, Crockett B, Foye MD, Gu Y, Campbell C, Butterfield RJ, Johnson NE (2018) Orofacial strength, dysarthria, and dysphagia in congenital myotonic dystrophy. Muscle Nerve 58(3):413\u2013417. https:\/\/doi.org\/10.1002\/mus.26176","journal-title":"Muscle Nerve"},{"issue":"5","key":"11_CR22","doi-asserted-by":"publisher","first-page":"a011387","DOI":"10.1101\/cshperspect.a011387","volume":"5","author":"P Bernardi","year":"2013","unstructured":"Bernardi P, Bonaldo P (2013) Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies. Cold Spring Harb Perspect Biol 5(5):a011387\u2013a011387. https:\/\/doi.org\/10.1101\/cshperspect.a011387","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"11_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.spen.2011.10.010","volume":"18","author":"E Bertini","year":"2011","unstructured":"Bertini E, D\u2019Amico A, Gualandi F, Petrini S (2011) Congenital muscular dystrophies: a brief review. Semin Pediatr Neurol 18(4):277\u2013288. https:\/\/doi.org\/10.1016\/j.spen.2011.10.010","journal-title":"Semin Pediatr Neurol"},{"issue":"32","key":"11_CR24","doi-asserted-by":"publisher","first-page":"13307","DOI":"10.1073\/pnas.0902312106","volume":"106","author":"M Bertz","year":"2009","unstructured":"Bertz M, Wilmanns M, Rief M (2009) The titin-telethonin complex is a directed, superstable molecular bond in the muscle Z-disk. Proc Natl Acad Sci 106(32):13307\u2013133310. https:\/\/doi.org\/10.1073\/pnas.0902312106","journal-title":"Proc Natl Acad Sci"},{"key":"11_CR25","unstructured":"Bird TD (2021) Myotonic dystrophy type 1. In GeneReviews. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1165\/"},{"issue":"17","key":"11_CR26","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1093\/hmg\/ddv219","volume":"24","author":"DR Bisset","year":"2015","unstructured":"Bisset DR, Stepniak-Konieczna EA, Zavaljevski M, Wei J, Carter GT, Weiss MD, Chamberlain JR (2015) Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. Hum Mol Genet 24(17):4971\u20134983. https:\/\/doi.org\/10.1093\/hmg\/ddv219","journal-title":"Hum Mol Genet"},{"issue":"15","key":"11_CR27","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.3390\/ijms21155575","volume":"21","author":"AJ Bittel","year":"2020","unstructured":"Bittel AJ, Sreetama SC, Bittel DC, Horn A, Novak JS, Yokota T, Zhang A, Maruyama R et al (2020) Membrane repair deficit in Facioscapulohumeral muscular dystrophy. Int J Mol Sci 21(15):5575. https:\/\/doi.org\/10.3390\/ijms21155575","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108632","volume":"27","author":"AJ Bittel","year":"2024","unstructured":"Bittel AJ, Bittel DC, Gordish-Dressman H, Chen Y-W (2024) Voluntary wheel running improves molecular and functional deficits in a murine model of facioscapulohumeral muscular dystrophy. iScience 27(1):108632. https:\/\/doi.org\/10.1016\/j.isci.2023.108632","journal-title":"iScience"},{"issue":"4","key":"11_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000505634","volume":"99","author":"M Boentert","year":"2020","unstructured":"Boentert M, Cao M, Mass D, De Mattia E, Falcier E, Goncalves M, Holland V, Katz SL, Orlikowski D, Sannicol\u00f2 G, Wijkstra P, Hellerstein L, Sansone VA (2020) Consensus-based care recommendations for pulmonologists treating adults with myotonic dystrophy type 1. Respiration 99(4):360\u2013368. https:\/\/doi.org\/10.1159\/000505634","journal-title":"Respiration"},{"issue":"6914","key":"11_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich S, Krag TOB, Barton ER, Morris LD, Whittemore L-A, Ahima RS, Khurana TS (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420(6914):418\u2013421. https:\/\/doi.org\/10.1038\/nature01154","journal-title":"Nature"},{"issue":"2","key":"11_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2009.12.013","volume":"86","author":"V Bolduc","year":"2010","unstructured":"Bolduc V, Marlow G, Boycott KM, Saleki K, Inoue H, Kroon J, Itakura M, Robitaille Y, Parent L, Baas F, Mizuta K, Kamata N, Richard I, Linssen WHJP, Mahjneh I, De Visser M, Bashir R, Brais B (2010) Recessive mutations in the putative calcium-activated Chloride Channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet 86(2):213\u2013221. https:\/\/doi.org\/10.1016\/j.ajhg.2009.12.013","journal-title":"Am J Hum Genet"},{"issue":"9","key":"11_CR32","doi-asserted-by":"publisher","first-page":"eaaw7781","DOI":"10.1126\/sciadv.aaw7781","volume":"5","author":"D Bosnakovski","year":"2019","unstructured":"Bosnakovski D, da Silva MT, Sunny ST, Ener ET, Toso EA, Yuan C, Cui Z, Walters MA, Jadhav A, Kyba M (2019) A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death. Sci Adv 5(9):eaaw7781. https:\/\/doi.org\/10.1126\/sciadv.aaw7781","journal-title":"Sci Adv"},{"issue":"9","key":"11_CR33","doi-asserted-by":"publisher","first-page":"13993","DOI":"10.1021\/acsnano.1c05099","volume":"15","author":"JP Bost","year":"2021","unstructured":"Bost JP, Barriga H, Holme MN, Gallud A, Maugeri M, Gupta D, Lehto T, Valadi H, Esbj\u00f6rner EK, Stevens MM, El-Andaloussi S (2021) Delivery of oligonucleotide therapeutics: chemical modifications, lipid nanoparticles, and extracellular vesicles. ACS Nano 15(9):13993\u201314021. https:\/\/doi.org\/10.1021\/acsnano.1c05099","journal-title":"ACS Nano"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.omtn.2021.09.010","volume":"26","author":"LF Bouwman","year":"2021","unstructured":"Bouwman LF, Den Hamer B, Van Den Heuvel A, Franken M, Jackson M, Dwyer CA, Tapscott SJ, Rigo F, Van Der Maarel SM, De Greef JC (2021) Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy. Mol Ther Nucleic Acids 26:813\u2013827. https:\/\/doi.org\/10.1016\/j.omtn.2021.09.010","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"11_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.880010204","volume":"1","author":"WG Bradley","year":"1978","unstructured":"Bradley WG, Jones MZ, Mussini J, Fawcett PRW (1978) Becker-type muscular dystrophy. Muscle Nerve 1(2):111\u2013132. https:\/\/doi.org\/10.1002\/mus.880010204","journal-title":"Muscle Nerve"},{"key":"11_CR36","unstructured":"BridgeBio (2023) BridgeBio Pharma shares positive long-term data from an ongoing phase 2 study, which support the potential use of glycosylated alpha-dystroglycan (\u237aDG) levels as a surrogate endpoint in limb-girdle muscular dystrophy type 2I\/R9 (LGMD2I\/R9). https:\/\/investor.bridgebio.com\/news-releases\/news-release-details\/bridgebio-pharma-shares-positive-long-term-data-ongoing-phase-2"},{"issue":"4","key":"11_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0960-8966(95)00005-8","volume":"5","author":"KMD Bushby","year":"1995","unstructured":"Bushby KMD, Beckmann JS (1995) 30th and 31st ENMC international workshops, Naarden, The Netherlands, held 6\u20138 January 1995. Neuromuscul Disord 5(4):337\u2013343. https:\/\/doi.org\/10.1016\/0960-8966(95)00005-8","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"11_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF00858725","volume":"240","author":"KMD Bushby","year":"1993","unstructured":"Bushby KMD, Gardner-Medwin D (1993) The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy: I. Natural history. J Neurol 240(2):98\u2013104. https:\/\/doi.org\/10.1007\/BF00858725","journal-title":"J Neurol"},{"issue":"1","key":"11_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77\u201393. https:\/\/doi.org\/10.1016\/S1474-4422(09)70271-6","journal-title":"Lancet Neurol"},{"issue":"1","key":"11_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","volume":"7","author":"AE Campbell","year":"2017","unstructured":"Campbell AE, Oliva J, Yates MP, Zhong JW, Shadle SC, Snider L, Singh N, Tai S, Hiramuki Y, Tawil R, Van Der Maarel SM, Tapscott SJ, Sverdrup FM (2017) BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skelet Muscle 7(1):16. https:\/\/doi.org\/10.1186\/s13395-017-0134-x","journal-title":"Skelet Muscle"},{"issue":"48","key":"11_CR41","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1093\/eurheartj\/ehad561","volume":"44","author":"DE Cannie","year":"2023","unstructured":"Cannie DE, Syrris P, Protonotarios A, Bakalakos A, Pruny J-F, Ditaranto R, Martinez-Veira C, Larra\u00f1aga-Moreira JM, Medo K, Berm\u00fadez-Jim\u00e9nez FJ, Ben Yaou R, Leturcq F, Mezcua AR, Marini-Bettolo C, Cabrera E, Reuter C, Limeres Freire J, Rodr\u00edguez-Palomares JF, Mestroni L et al (2023) Emery\u2013Dreifuss muscular dystrophy type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure. Eur Heart J 44(48):5064\u20135073. https:\/\/doi.org\/10.1093\/eurheartj\/ehad561","journal-title":"Eur Heart J"},{"issue":"1","key":"11_CR42","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1038\/s41467-018-05990-z","volume":"9","author":"MP Cataldi","year":"2018","unstructured":"Cataldi MP, Lu P, Blaeser A, Lu QL (2018) Ribitol restores functionally glycosylated \u03b1-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice. Nat Commun 9(1):3448. https:\/\/doi.org\/10.1038\/s41467-018-05990-z","journal-title":"Nat Commun"},{"issue":"19","key":"11_CR43","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1002\/pmic.200600056","volume":"6","author":"B Celegato","year":"2006","unstructured":"Celegato B, Capitanio D, Pescatori M, Romualdi C, Pacchioni B, Cagnin S, Vigan\u00f2 A, Colantoni L, Begum S, Ricci E, Wait R, Lanfranchi G, Gelfi C (2006) Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6(19):5303\u20135321. https:\/\/doi.org\/10.1002\/pmic.200600056","journal-title":"Proteomics"},{"issue":"1","key":"11_CR44","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41467-018-04892-4","volume":"9","author":"E Cerro-Herreros","year":"2018","unstructured":"Cerro-Herreros E, Sabater-Arcis M, Fernandez-Costa JM, Moreno N, Perez-Alonso M, Llamusi B, Artero R (2018) miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models. Nat Commun 9(1):2482. https:\/\/doi.org\/10.1038\/s41467-018-04892-4","journal-title":"Nat Commun"},{"issue":"6","key":"11_CR45","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1373\/clinchem.2017.276980","volume":"64","author":"S Chakravorty","year":"2018","unstructured":"Chakravorty S, Hegde M (2018) Clinical utility of transcriptome sequencing: toward a better diagnosis for Mendelian disorders. Clin Chem 64(6):882\u2013884. https:\/\/doi.org\/10.1373\/clinchem.2017.276980","journal-title":"Clin Chem"},{"issue":"1","key":"11_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-019-0197-z","volume":"5","author":"G Chandra","year":"2019","unstructured":"Chandra G, Defour A, Mamchoui K, Pandey K, Mishra S, Mouly V, Sreetama S, Mahad Ahmad M, Mahjneh I, Morizono H, Pattabiraman N, Menon AK, Jaiswal JK (2019) Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5\/TMEM16E-deficient patient muscle cells. Cell Death Dis 5(1):118. https:\/\/doi.org\/10.1038\/s41420-019-0197-z","journal-title":"Cell Death Dis"},{"issue":"5","key":"11_CR47","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202006035","volume":"220","author":"G Chandra","year":"2021","unstructured":"Chandra G, Sreetama SC, M\u00e1zala DAG, Charton K, VanderMeulen JH, Richard I, Jaiswal JK (2021) Endoplasmic reticulum maintains ion homeostasis required for plasma membrane repair. J Cell Biol 220(5):e202006035. https:\/\/doi.org\/10.1083\/jcb.202006035","journal-title":"J Cell Biol"},{"issue":"4","key":"11_CR48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.nmd.2013.01.005","volume":"23","author":"T-H Chen","year":"2013","unstructured":"Chen T-H, Lai Y-H, Lee P-L, Hsu J-H, Goto K, Hayashi YK, Nishino I, Lin C-W, Shih H-H, Huang C-C, Liang W-C, Wang W-F, Jong Y-J (2013) Infantile facioscapulohumeral muscular dystrophy revisited: expansion of clinical phenotypes in patients with a very short EcoRI fragment. Neuromuscul Disord 23(4):298\u2013305. https:\/\/doi.org\/10.1016\/j.nmd.2013.01.005","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"11_CR49","doi-asserted-by":"publisher","first-page":"25317","DOI":"10.1038\/srep25317","volume":"6","author":"G Chen","year":"2016","unstructured":"Chen G, Masuda A, Konishi H, Ohkawara B, Ito M, Kinoshita M, Kiyama H, Matsuura T, Ohno K (2016a) Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy. Sci Rep 6(1):25317. https:\/\/doi.org\/10.1038\/srep25317","journal-title":"Sci Rep"},{"issue":"8","key":"11_CR50","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/mt.2016.111","volume":"24","author":"JC Chen","year":"2016","unstructured":"Chen JC, King OD, Zhang Y, Clayton NP, Spencer C, Wentworth BM, Emerson CP, Wagner KR (2016b) Morpholino-mediated knockdown of DUX4 toward Facioscapulohumeral muscular dystrophy therapeutics. Mol Ther 24(8):1405\u20131411. https:\/\/doi.org\/10.1038\/mt.2016.111","journal-title":"Mol Ther"},{"issue":"4","key":"11_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s13311-018-0648-x","volume":"15","author":"ML Chu","year":"2018","unstructured":"Chu ML, Moran E (2018) The limb\u2013girdle muscular dystrophies: is treatment on the horizon? Neurotherapeutics 15(4):849\u2013862. https:\/\/doi.org\/10.1007\/s13311-018-0648-x","journal-title":"Neurotherapeutics"},{"issue":"2","key":"11_CR52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1086\/519311","volume":"81","author":"J Clapp","year":"2007","unstructured":"Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, Armour JAL, Hewitt JE (2007) Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 81(2):264\u2013279. https:\/\/doi.org\/10.1086\/519311","journal-title":"Am J Hum Genet"},{"key":"11_CR53","unstructured":"ClinicalTrials.gov (2023a) A study of Deflazacort (Emflaza\u00ae) in participants with Limb-Girdle Muscular Dystrophy 2I (LGMD2I). ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03783923"},{"key":"11_CR54","unstructured":"ClinicalTrials.gov (2023b) A trial of PF-06252616 in ambulatory participants with LGMD2I. https:\/\/clinicaltrials.gov\/study\/NCT02841267"},{"key":"11_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella P, Ronzitti G, Mingozzi F (2018) Emerging issues in AAV-mediated in vivo gene therapy. Mol Ther Methods Clin Dev 8:87\u2013104. https:\/\/doi.org\/10.1016\/j.omtm.2017.11.007","journal-title":"Mol Ther Methods Clin Dev"},{"key":"11_CR56","unstructured":"Cooper D, Upadhhyaya M (n.d.) Facioscapulohumeral muscular dystrophy (FSHD): clinical medicine and molecular cell biology. Garland Science"},{"issue":"386","key":"11_CR57","doi-asserted-by":"publisher","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","volume":"9","author":"BB Cummings","year":"2017","unstructured":"Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR, Bolduc V, Waddell LB, Sandaradura SA, O\u2019Grady GL, Estrella E, Reddy HM, Zhao F, Weisburd B, Karczewski KJ, O\u2019Donnell-Luria AH, Birnbaum D, Sarkozy A, Hu Y et al (2017) Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med 9(386):eaal5209. https:\/\/doi.org\/10.1126\/scitranslmed.aal5209","journal-title":"Sci Transl Med"},{"issue":"4","key":"11_CR58","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","volume":"60","author":"JW Day","year":"2003","unstructured":"Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LPW (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60(4):657\u2013664. https:\/\/doi.org\/10.1212\/01.WNL.0000054481.84978.F9","journal-title":"Neurology"},{"issue":"10","key":"11_CR59","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","volume":"172","author":"M De Antonio","year":"2016","unstructured":"De Antonio M, Dogan C, Hamroun D, Mati M, Zerrouki S, Eymard B, Katsahian S, Bassez G (2016) Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification. Rev Neurol 172(10):572\u2013580. https:\/\/doi.org\/10.1016\/j.neurol.2016.08.003","journal-title":"Rev Neurol"},{"issue":"12","key":"11_CR60","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","volume":"83","author":"JCW Deenen","year":"2014","unstructured":"Deenen JCW, Arnts H, van der Maarel SM, Padberg GW, Verschuuren JJGM, Bakker E, Weinreich SS, Verbeek ALM, van Engelen BGM (2014) Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 83(12):1056\u20131059. https:\/\/doi.org\/10.1212\/WNL.0000000000000797","journal-title":"Neurology"},{"issue":"10","key":"11_CR61","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp-2017-317488","volume":"89","author":"J Diaz-Manera","year":"2018","unstructured":"Diaz-Manera J, Fernandez-Torron R et al (2018) Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials. J Neurol Neurosurg Psychiatry 89(10):1071\u20131081. https:\/\/doi.org\/10.1136\/jnnp-2017-317488","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"46","key":"11_CR62","doi-asserted-by":"publisher","first-page":"18157","DOI":"10.1073\/pnas.0708659104","volume":"104","author":"M Dixit","year":"2007","unstructured":"Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Matt\u00e9otti C, van Acker AM, Leo O, Figlewicz D, Barro M, Laoudj-Chenivesse D, Belayew A, Copp\u00e9e F, Chen Y-W (2007) DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci 104(46):18157\u201318162. https:\/\/doi.org\/10.1073\/pnas.0708659104","journal-title":"Proc Natl Acad Sci"},{"key":"11_CR63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.mcn.2013.04.005","volume":"56","author":"AGL Douglas","year":"2013","unstructured":"Douglas AGL, Wood MJA (2013) Splicing therapy for neuromuscular disease. Mol Cell Neurosci 56:169\u2013185. https:\/\/doi.org\/10.1016\/j.mcn.2013.04.005","journal-title":"Mol Cell Neurosci"},{"key":"11_CR64","doi-asserted-by":"publisher","unstructured":"Dowling P, Swandulla D, Ohlendieck K (2023) Cellular pathogenesis of Duchenne muscular dystrophy: progressive myofibre degeneration, chronic inflammation, reactive myofibrosis and satellite cell dysfunction. Eur J Transl Myol 33. https:\/\/doi.org\/10.4081\/ejtm.2023.11856","DOI":"10.4081\/ejtm.2023.11856"},{"issue":"1","key":"11_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Prim 7(1):13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3","journal-title":"Nat Rev Dis Prim"},{"issue":"3","key":"11_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1152\/physiolgenomics.2000.3.3.133","volume":"3","author":"S Ebihara","year":"2000","unstructured":"Ebihara S, Guibinga G-H, Gilbert R, Nalbantoglu J, Massie B, Karpati G, Petrof BJ (2000) Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiol Genomics 3(3):133\u2013144. https:\/\/doi.org\/10.1152\/physiolgenomics.2000.3.3.133","journal-title":"Physiol Genomics"},{"issue":"4","key":"11_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1399-0004.1976.tb00033.x","volume":"10","author":"AEH Emery","year":"1976","unstructured":"Emery AEH, Skinner R (1976) Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 10(4):189\u2013201. https:\/\/doi.org\/10.1111\/j.1399-0004.1976.tb00033.x","journal-title":"Clin Genet"},{"issue":"5","key":"11_CR68","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mus.25367","volume":"54","author":"M Fanin","year":"2016","unstructured":"Fanin M, Angelini C (2016) Progress and challenges in diagnosis of dysferlinopathy: Dysferlinopathy diagnosis. Muscle Nerve 54(5):821\u2013835. https:\/\/doi.org\/10.1002\/mus.25367","journal-title":"Muscle Nerve"},{"key":"11_CR69","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04996","volume":"4","author":"Q Feng","year":"2015","unstructured":"Feng Q, Snider L, Jagannathan S, Tawil R, Van Der Maarel SM, Tapscott SJ, Bradley RK (2015) A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. elife 4:e04996. https:\/\/doi.org\/10.7554\/eLife.04996","journal-title":"elife"},{"key":"11_CR70","unstructured":"Figueiredo M (n.d.) Acceleron abandons development of ACE-083 in FSH. Biotherapues Institute. https:\/\/www.institut-myologie.org\/en\/2022\/07\/12\/acceleron-abandons-development-of-ace-083-in-fsh\/"},{"key":"11_CR71","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.omtn.2023.05.017","volume":"32","author":"AR Findlay","year":"2023","unstructured":"Findlay AR, Paing MM, Daw JA, Haller M, Bengoechea R, Pittman SK, Li S, Wang F, Miller TM, True HL, Chou T-F, Weihl CC (2023) DNAJB6 isoform specific knockdown: therapeutic potential for limb girdle muscular dystrophy D1. Mol Ther Nucleic Acids 32:937\u2013948. https:\/\/doi.org\/10.1016\/j.omtn.2023.05.017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"11_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000068446","volume":"99","author":"J Finsterer","year":"2003","unstructured":"Finsterer J, St\u00f6llberger C (2003) The heart in human Dystrophinopathies. Cardiology 99(1):1\u201319. https:\/\/doi.org\/10.1159\/000068446","journal-title":"Cardiology"},{"issue":"10","key":"11_CR73","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0828-282X(08)70686-X","volume":"24","author":"J Finsterer","year":"2008","unstructured":"Finsterer J, St\u00f6llberger C (2008) Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 24(10):786\u2013792. https:\/\/doi.org\/10.1016\/S0828-282X(08)70686-X","journal-title":"Can J Cardiol"},{"issue":"6\u20137","key":"11_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0960-8966(01)00201-2","volume":"11","author":"KM Flanigan","year":"2001","unstructured":"Flanigan KM, Coffeen CM, Sexton L, Stauffer D, Brunner S, Leppert MF (2001) Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul Disord 11(6\u20137):525\u2013529. https:\/\/doi.org\/10.1016\/S0960-8966(01)00201-2","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"11_CR75","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202007059","volume":"220","author":"SJ Foltz","year":"2021","unstructured":"Foltz SJ, Cui YY, Choo HJ, Hartzell HC (2021) ANO5 ensures trafficking of annexins in wounded myofibers. J Cell Biol 220(3):e202007059. https:\/\/doi.org\/10.1083\/jcb.202007059","journal-title":"J Cell Biol"},{"issue":"11","key":"11_CR76","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1172\/JCI82768","volume":"125","author":"QQ Gao","year":"2015","unstructured":"Gao QQ, Wyatt E, Goldstein JA, LoPresti P, Castillo LM, Gazda A, Petrossian N, Earley JU, Hadhazy M, Barefield DY, Demonbreun AR, B\u00f6nnemann C, Wolf M, McNally EM (2015) Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest 125(11):4186\u20134195. https:\/\/doi.org\/10.1172\/JCI82768","journal-title":"J Clin Invest"},{"issue":"5","key":"11_CR77","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/ijms23052901","volume":"23","author":"M Garc\u00eda-Puga","year":"2022","unstructured":"Garc\u00eda-Puga M, Saenz-Anto\u00f1anzas A, Matheu A, L\u00f3pez De Munain A (2022) Targeting myotonic dystrophy type 1 with metformin. Int J Mol Sci 23(5):2901. https:\/\/doi.org\/10.3390\/ijms23052901","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","volume":"22","author":"LN Geng","year":"2012","unstructured":"Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, van der Maarel SM, Ruzzo WL, Gentleman RC, Tawil R, Tapscott SJ (2012) DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 22(1):38\u201351. https:\/\/doi.org\/10.1016\/j.devcel.2011.11.013","journal-title":"Dev Cell"},{"issue":"4","key":"11_CR79","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10930-021-10006-9","volume":"40","author":"DG Georganopoulou","year":"2021","unstructured":"Georganopoulou DG, Moisiadis VG, Malik FA, Mohajer A, Dashevsky TM, Wuu ST, Hu C-K (2021) A journey with LGMD: from protein abnormalities to patient impact. Protein J 40(4):466\u2013488. https:\/\/doi.org\/10.1007\/s10930-021-10006-9","journal-title":"Protein J"},{"issue":"10","key":"11_CR80","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/brain\/awm212","volume":"130","author":"C Godfrey","year":"2007","unstructured":"Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, Jimenez-Mallebrera C, Mercuri E, Manzur AY, Kinali M, Torelli S, Brown SC, Sewry CA, Bushby K, Topaloglu H et al (2007) Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 130(10):2725\u20132735. https:\/\/doi.org\/10.1093\/brain\/awm212","journal-title":"Brain"},{"issue":"3","key":"11_CR81","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gde.2011.02.001","volume":"21","author":"C Godfrey","year":"2011","unstructured":"Godfrey C, Foley AR, Clement E, Muntoni F (2011) Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 21(3):278\u2013285. https:\/\/doi.org\/10.1016\/j.gde.2011.02.001","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"11_CR82","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.25326","volume":"84","author":"RJM Goselink","year":"2018","unstructured":"Goselink RJM, Schreuder THA, Van Alfen N, De Groot IJM, Jansen M, Lemmers RJLF, Van Der Vliet PJ, Van Der Stoep N, Theelen T, Voermans NC, Van Der Maarel SM, Van Engelen BGM, Erasmus CE (2018) Facioscapulohumeral dystrophy in childhood: a Nationwide natural history study. Ann Neurol 84(5):627\u2013637. https:\/\/doi.org\/10.1002\/ana.25326","journal-title":"Ann Neurol"},{"issue":"6","key":"11_CR83","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI0216098","volume":"110","author":"E Gussoni","year":"2002","unstructured":"Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, Stein J, Chan Y, Lidov HG, B\u00f6nnemann CG, Von Moers A, Morris GE, Den Dunnen JT, Chamberlain JS, Kunkel LM, Weinberg K (2002) Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 110(6):807\u2013814. https:\/\/doi.org\/10.1172\/JCI0216098","journal-title":"J Clin Invest"},{"issue":"23","key":"11_CR84","doi-asserted-by":"publisher","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","volume":"94","author":"K Hamanaka","year":"2020","unstructured":"Hamanaka K, \u0160ikrov\u00e1 D, Mitsuhashi S, Masuda H, Sekiguchi Y, Sugiyama A, Shibuya K, Lemmers RJLF, Goossens R, Ogawa M, Nagao K, Obuse C, Noguchi S, Hayashi YK, Kuwabara S, Balog J, Nishino I, Van Der Maarel SM (2020) Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology 94(23):e2441. https:\/\/doi.org\/10.1212\/WNL.0000000000009617","journal-title":"Neurology"},{"issue":"4","key":"11_CR85","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","volume":"15","author":"J Hamel","year":"2018","unstructured":"Hamel J, Tawil R (2018) Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments. Neurotherapeutics 15(4):863\u2013871. https:\/\/doi.org\/10.1007\/s13311-018-00675-3","journal-title":"Neurotherapeutics"},{"issue":"4","key":"11_CR86","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ceb.2007.07.001","volume":"19","author":"R Han","year":"2007","unstructured":"Han R, Campbell KP (2007) Dysferlin and muscle membrane repair. Curr Opin Cell Biol 19(4):409\u2013416. https:\/\/doi.org\/10.1016\/j.ceb.2007.07.001","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"11_CR87","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-017-0699-9","volume":"12","author":"E Harris","year":"2017","unstructured":"Harris E, Topf A, Barresi R, Hudson J, Powell H, Tellez J, Hicks D, Porter A, Bertoli M, Evangelista T, Marini-Betollo C, Magn\u00fasson \u00d3, Lek M, MacArthur D, Bushby K, Lochm\u00fcller H, Straub V (2017) Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy. Orphanet J Rare Dis 12(1):151. https:\/\/doi.org\/10.1186\/s13023-017-0699-9","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"11_CR88","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00439-006-0254-6","volume":"120","author":"H Hayashi","year":"2006","unstructured":"Hayashi H, Nagae G, Tsutsumi S, Kaneshiro K, Kozaki T, Kaneda A, Sugisaki H, Aburatani H (2006) High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array. Hum Genet 120(5):701\u2013711. https:\/\/doi.org\/10.1007\/s00439-006-0254-6","journal-title":"Hum Genet"},{"issue":"2","key":"11_CR89","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jcsm.13171","volume":"14","author":"CR Heier","year":"2023","unstructured":"Heier CR, McCormack NM, Tully CB, Novak JS, Newell-Stamper BL, Russell AJ, Fiorillo AA (2023) The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45\u201347. J Cachexia Sarcopenia Muscle 14(2):940\u2013954. https:\/\/doi.org\/10.1002\/jcsm.13171","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"11_CR90","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/mt.2015.200","volume":"24","author":"CL Himeda","year":"2016","unstructured":"Himeda CL, Jones TI, Jones PL (2016) CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy. Mol Ther 24(3):527\u2013535. https:\/\/doi.org\/10.1038\/mt.2015.200","journal-title":"Mol Ther"},{"issue":"22","key":"11_CR91","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1242\/jcs.110.22.2873","volume":"110","author":"BL Hodges","year":"1997","unstructured":"Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ (1997) Altered expression of the \u03b17\u03b21 integrin in human and murine muscular dystrophies. J Cell Sci 110(22):2873\u20132881. https:\/\/doi.org\/10.1242\/jcs.110.22.2873","journal-title":"J Cell Sci"},{"issue":"6","key":"11_CR92","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51(6):919\u2013928. https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4","journal-title":"Cell"},{"issue":"21","key":"11_CR93","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJM198805263182104","volume":"318","author":"EP Hoffman","year":"1988","unstructured":"Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loire JD, Harris JB, Waterston R, Brooke M, Specht L, Kupsky W, Chamberlain J, Caskey CT, Shapiro F, Kunkel LM (1988) Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne\u2019s or Becker\u2019s muscular dystrophy. N Engl J Med 318(21):1363\u20131368. https:\/\/doi.org\/10.1056\/NEJM198805263182104","journal-title":"N Engl J Med"},{"issue":"1620","key":"11_CR94","doi-asserted-by":"publisher","first-page":"20120369","DOI":"10.1098\/rstb.2012.0369","volume":"368","author":"SJB Holwerda","year":"2013","unstructured":"Holwerda SJB, De Laat W (2013) CTCF: the protein, the binding partners, the binding sites and their chromatin loops. Philos Trans R Soc B Biol Sci 368(1620):20120369. https:\/\/doi.org\/10.1098\/rstb.2012.0369","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"11_CR95","doi-asserted-by":"publisher","first-page":"15042","DOI":"10.1038\/mtm.2015.42","volume":"2","author":"EM Houang","year":"2015","unstructured":"Houang EM, Haman KJ, Filareto A, Perlingeiro RC, Bates FS, Lowe DA, Metzger JM (2015) Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo. Mol Ther Methods Clin Dev 2:15042. https:\/\/doi.org\/10.1038\/mtm.2015.42","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6","key":"11_CR96","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1021\/acs.biochem.7b01239","volume":"57","author":"W-C Hsieh","year":"2018","unstructured":"Hsieh W-C, Bahal R, Thadke SA, Bhatt K, Sobczak K, Thornton C, Ly DH (2018) Design of a \u201cmini\u201d nucleic acid probe for cooperative binding of an RNA-repeated transcript associated with myotonic dystrophy type 1. Biochemistry 57(6):907\u2013911. https:\/\/doi.org\/10.1021\/acs.biochem.7b01239","journal-title":"Biochemistry"},{"issue":"12","key":"11_CR97","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/hmg\/ddn081","volume":"17","author":"Y Huang","year":"2008","unstructured":"Huang Y, De Morr\u00e9e A, Van Remoortere A, Bushby K, Frants RR, Dunnen JT, Van Der Maarel SM (2008) Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum Mol Genet 17(12):1855\u20131866. https:\/\/doi.org\/10.1093\/hmg\/ddn081","journal-title":"Hum Mol Genet"},{"issue":"2","key":"11_CR98","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/hmg\/dds434","volume":"22","author":"M Ibrahim","year":"2013","unstructured":"Ibrahim M, Siedlecka U, Buyandelger B, Harada M, Rao C, Moshkov A, Bhargava A, Schneider M, Yacoub MH, Gorelik J, Knoll R, Terracciano CM (2013) A critical role for Telethonin in regulating t-tubule structure and function in the mammalian heart. Hum Mol Genet 22(2):372\u2013383. https:\/\/doi.org\/10.1093\/hmg\/dds434","journal-title":"Hum Mol Genet"},{"issue":"1","key":"11_CR99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0854.2006.00505.x","volume":"8","author":"JK Jaiswal","year":"2007","unstructured":"Jaiswal JK, Marlow G, Summerill G, Mahjneh I, Mueller S, Hill M, Miyake K, Haase H, Anderson LVB, Richard I, Kiuru-Enari S, McNeil PL, Simon SM, Bashir R (2007) Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Traffic 8(1):77\u201388. https:\/\/doi.org\/10.1111\/j.1600-0854.2006.00505.x","journal-title":"Traffic"},{"issue":"2","key":"11_CR100","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.apmr.2007.08.153","volume":"89","author":"MP Jensen","year":"2008","unstructured":"Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM (2008) Chronic pain in persons with myotonic dystrophy and Facioscapulohumeral dystrophy. Arch Phys Med Rehabil 89(2):320\u2013328. https:\/\/doi.org\/10.1016\/j.apmr.2007.08.153","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"11_CR101","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1750-3639.2008.00198.x","volume":"19","author":"C Jimenez-Mallebrera","year":"2009","unstructured":"Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, Clement E, Mein R, Abbs S, Brown SC, Campbell KP, Kr\u00f6ger S, Talim B, Topaloglu H, Quinlivan R, Roper H, Childs AM, Kinali M, Sewry CA, Muntoni F (2009) A comparative study of \u03b1-Dystroglycan glycosylation in Dystroglycanopathies suggests that the Hypoglycosylation of \u03b1-Dystroglycan does not consistently correlate with clinical severity. Brain Pathol 19(4):596\u2013611. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00198.x","journal-title":"Brain Pathol"},{"issue":"6","key":"11_CR102","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/CON.0000000000001178","volume":"28","author":"NE Johnson","year":"2022","unstructured":"Johnson NE, Statland JM (2022) The limb-girdle muscular dystrophies. Neurol Clin 28(6):1698\u20131714. https:\/\/doi.org\/10.1212\/CON.0000000000001178","journal-title":"Neurol Clin"},{"issue":"2","key":"11_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192657","volume":"13","author":"T Jones","year":"2018","unstructured":"Jones T, Jones PL (2018) A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy. PLoS One 13(2):e0192657. https:\/\/doi.org\/10.1371\/journal.pone.0192657","journal-title":"PLoS One"},{"key":"11_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-2-31","volume":"2","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth H (2007) Multi-minicore Disease. Orphanet J Rare Dis 2:31. https:\/\/doi.org\/10.1186\/1750-1172-2-31","journal-title":"Orphanet J Rare Dis"},{"key":"11_CR105","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fnagi.2014.00339","volume":"6","author":"H Jungbluth","year":"2014","unstructured":"Jungbluth H, Gautel M (2014) Pathogenic mechanisms in centronuclear myopathies. Front Aging Neurosci 6:339. https:\/\/doi.org\/10.3389\/fnagi.2014.00339","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"11_CR106","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3390\/biomedicines11092339","volume":"11","author":"T Kakimoto","year":"2023","unstructured":"Kakimoto T, Ogasawara A, Ishikawa K, Kurita T, Yoshida K, Harada S, Nonaka T, Inoue Y, Uchida K, Tateoka T, Ohta T, Kumagai S, Sasaki T, Aihara H (2023) A systemically administered unconjugated antisense oligonucleotide targeting DUX4 improves muscular injury and motor function in FSHD model mice. Biomedicines 11(9):2339. https:\/\/doi.org\/10.3390\/biomedicines11092339","journal-title":"Biomedicines"},{"key":"11_CR107","doi-asserted-by":"publisher","first-page":"1055639","DOI":"10.3389\/fneur.2023.1055639","volume":"14","author":"M Katz","year":"2023","unstructured":"Katz M, Waddell LB, Yuen M, Bryen SJ, Oates E, Garton FC, Robertson T, Henderson RD, Cooper ST, McCombe PA (2023) Case report: adult-onset limb girdle muscular dystrophy in sibling pair due to novel homozygous LAMA2 missense variant. Front Neurol 14:1055639. https:\/\/doi.org\/10.3389\/fneur.2023.1055639","journal-title":"Front Neurol"},{"issue":"19","key":"11_CR108","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1093\/nar\/gkp681","volume":"37","author":"Y Kino","year":"2009","unstructured":"Kino Y, Washizu C, Oma Y, Onishi H, Nezu Y, Sasagawa N, Nukina N, Ishiura S (2009) MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res 37(19):6477\u20136490. https:\/\/doi.org\/10.1093\/nar\/gkp681","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"11_CR109","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1212\/WNL.41.5.667","volume":"41","author":"JT Kissel","year":"1991","unstructured":"Kissel JT, Burrow KL, Rammohan KW, Mendell JR et al (1991) Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. Neurology 41(5):667\u2013672. https:\/\/doi.org\/10.1212\/WNL.41.5.667","journal-title":"Neurology"},{"issue":"8","key":"11_CR110","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","volume":"57","author":"JT Kissel","year":"2001","unstructured":"Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S et al (2001) Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57(8):1434\u20131440. https:\/\/doi.org\/10.1212\/WNL.57.8.1434","journal-title":"Neurology"},{"issue":"5","key":"11_CR111","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/cells9051119","volume":"9","author":"A Klimczak","year":"2020","unstructured":"Klimczak A, Zimna A, Malcher A, Kozlowska U, Futoma K, Czarnota J, Kemnitz P, Bryl A, Kurpisz M (2020) Co-transplantation of bone marrow-MSCs and myogenic stem\/progenitor cells from adult donors improves muscle function of patients with Duchenne muscular dystrophy. Cells 9(5):1119. https:\/\/doi.org\/10.3390\/cells9051119","journal-title":"Cells"},{"issue":"9\u201310","key":"11_CR112","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.nmd.2006.06.008","volume":"16","author":"L Klinge","year":"2006","unstructured":"Klinge L, Eagle M, Haggerty ID, Roberts CE, Straub V, Bushby KM (2006) Severe phenotype in infantile facioscapulohumeral muscular dystrophy. Neuromuscul Disord 16(9\u201310):553\u2013558. https:\/\/doi.org\/10.1016\/j.nmd.2006.06.008","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"11_CR113","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.3390\/jcm9123939","volume":"9","author":"E Koehorst","year":"2020","unstructured":"Koehorst E, Ballester-Lopez A, Arechavala-Gomeza V, Mart\u00ednez-Pi\u00f1eiro A, Nogales-Gadea G (2020) The biomarker potential of miRNAs in myotonic dystrophy type I. J Clin Med 9(12):3939. https:\/\/doi.org\/10.3390\/jcm9123939","journal-title":"J Clin Med"},{"issue":"2","key":"11_CR114","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1089\/hum.2013.164","volume":"25","author":"T Koo","year":"2014","unstructured":"Koo T, Popplewell L, Athanasopoulos T, Dickson G (2014) Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Hum Gene Ther 25(2):98\u2013108. https:\/\/doi.org\/10.1089\/hum.2013.164","journal-title":"Hum Gene Ther"},{"issue":"10","key":"11_CR115","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/ph13100306","volume":"13","author":"S Kourakis","year":"2020","unstructured":"Kourakis S, Timpani CA, De Haan JB, Gueven N, Fischer D, Rybalka E (2020) Dimethyl fumarate and its esters: a drug with broad clinical utility? Pharmaceuticals 13(10):306. https:\/\/doi.org\/10.3390\/ph13100306","journal-title":"Pharmaceuticals"},{"issue":"21","key":"11_CR116","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1093\/hmg\/ddn223","volume":"17","author":"I Kramerova","year":"2008","unstructured":"Kramerova I, Kudryashova E, Wu B, Ottenheijm C, Granzier H, Spencer MJ (2008) Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum Mol Genet 17(21):3271\u20133280. https:\/\/doi.org\/10.1093\/hmg\/ddn223","journal-title":"Hum Mol Genet"},{"issue":"2","key":"11_CR117","doi-asserted-by":"publisher","first-page":"C253","DOI":"10.1152\/ajpcell.00321.2019","volume":"318","author":"TA Kwiatkowski","year":"2020","unstructured":"Kwiatkowski TA, Rose AL, Jung R, Capati A, Hallak D, Yan R, Weisleder N (2020) Multiple poloxamers increase plasma membrane repair capacity in muscle and nonmuscle cells. Am J Phys Cell Phys 318(2):C253\u2013C262. https:\/\/doi.org\/10.1152\/ajpcell.00321.2019","journal-title":"Am J Phys Cell Phys"},{"issue":"1","key":"11_CR118","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13395-020-00253-2","volume":"10","author":"M Kyba","year":"2020","unstructured":"Kyba M, Bloch RJ, Dumonceaux J, Harper SQ, Van Der Maarel SM, Sverdrup FM, Wagner KR, Van Engelen B, Chen Y-W (2020) Meeting report: the 2020 FSHD international research congress. Skelet Muscle 10(1):36. https:\/\/doi.org\/10.1186\/s13395-020-00253-2","journal-title":"Skelet Muscle"},{"issue":"4","key":"11_CR119","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s00415-019-09228-w","volume":"266","author":"E Landfeldt","year":"2019","unstructured":"Landfeldt E, Nikolenko N, Jimenez-Moreno C, Cumming S, Monckton DG, Gorman G, Turner C, Lochm\u00fcller H (2019) Disease burden of myotonic dystrophy type 1. J Neurol 266(4):998\u20131006. https:\/\/doi.org\/10.1007\/s00415-019-09228-w","journal-title":"J Neurol"},{"issue":"11","key":"11_CR120","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1073\/pnas.1117019109","volume":"109","author":"JE Lee","year":"2012","unstructured":"Lee JE, Bennett CF, Cooper TA (2012) RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc Natl Acad Sci 109(11):4221\u20134226. https:\/\/doi.org\/10.1073\/pnas.1117019109","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"11_CR121","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1471-2148-10-364","volume":"10","author":"A Leidenroth","year":"2010","unstructured":"Leidenroth A, Hewitt JE (2010) A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene. BMC Evol Biol 10(1):364. https:\/\/doi.org\/10.1186\/1471-2148-10-364","journal-title":"BMC Evol Biol"},{"issue":"5","key":"11_CR122","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00412-012-0380-y","volume":"121","author":"A Leidenroth","year":"2012","unstructured":"Leidenroth A, Clapp J, Mitchell LM, Coneyworth D, Dearden FL, Iannuzzi L, Hewitt JE (2012) Evolution of DUX gene macrosatellites in placental mammals. Chromosoma 121(5):489\u2013497. https:\/\/doi.org\/10.1007\/s00412-012-0380-y","journal-title":"Chromosoma"},{"issue":"536","key":"11_CR123","doi-asserted-by":"publisher","first-page":"eaay0271","DOI":"10.1126\/scitranslmed.aay0271","volume":"12","author":"A Lek","year":"2020","unstructured":"Lek A, Zhang Y, Woodman KG, Huang S, DeSimone AM, Cohen J, Ho V, Conner J, Mead L, Kodani A, Pakula A, Sanjana N, King OD, Jones PL, Wagner KR, Lek M, Kunkel LM (2020) Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophy. Sci Transl Med 12(536):eaay0271. https:\/\/doi.org\/10.1126\/scitranslmed.aay0271","journal-title":"Sci Transl Med"},{"issue":"5999","key":"11_CR124","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJLF Lemmers","year":"2010","unstructured":"Lemmers RJLF, van der Vliet PJ, Klooster R, Sacconi S, Cama\u00f1o P, Dauwerse JG, Snider L, Straasheijm KR, Jan van Ommen G, Padberg GW, Miller DG, Tapscott SJ, Tawil R, Frants RR, van der Maarel SM (2010) A unifying genetic model for Facioscapulohumeral muscular dystrophy. Science 329(5999):1650\u20131653. https:\/\/doi.org\/10.1126\/science.1189044","journal-title":"Science"},{"issue":"12","key":"11_CR125","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJLF Lemmers","year":"2012","unstructured":"Lemmers RJLF, Tawil R, Petek LM, Balog J, Block GJ, Santen GWE, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, Krom YD, Klooster R, Sun Y, den Dunnen JT, Helmer Q, Donlin-Smith CM, Padberg GW, van Engelen BGM, de Greef JC et al (2012) Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 44(12):1370\u20131374. https:\/\/doi.org\/10.1038\/ng.2454","journal-title":"Nat Genet"},{"issue":"5","key":"11_CR126","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1525-0016(16)42835-2","volume":"5","author":"J Li","year":"2002","unstructured":"Li J, Liu PXQ, Wang B, Xiao X (2002) Protein trans-splicing as a novel strategy for Duchenne muscular dystrophy gene therapy with AAV vectors. Mol Ther 5(5):S3. https:\/\/doi.org\/10.1016\/S1525-0016(16)42835-2","journal-title":"Mol Ther"},{"issue":"3","key":"11_CR127","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000524734","volume":"56","author":"Q Liao","year":"2022","unstructured":"Liao Q, Zhang Y, He J, Huang K (2022) Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis. Neuroepidemiology 56(3):163\u2013173. https:\/\/doi.org\/10.1159\/000524734","journal-title":"Neuroepidemiology"},{"issue":"2","key":"11_CR128","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mus.26077","volume":"58","author":"T Liewluck","year":"2018","unstructured":"Liewluck T, Milone M (2018) Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 58(2):167\u2013177. https:\/\/doi.org\/10.1002\/mus.26077","journal-title":"Muscle Nerve"},{"issue":"2","key":"11_CR129","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/ejhg.2011.179","volume":"20","author":"S Lillis","year":"2012","unstructured":"Lillis S, Abbs S, Mueller CR, Muntoni F, Jungbluth H (2012) Clinical utility gene card for: central core disease. Eur J Hum Genet 20(2):5\u20135. https:\/\/doi.org\/10.1038\/ejhg.2011.179","journal-title":"Eur J Hum Genet"},{"issue":"17","key":"11_CR130","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1093\/hmg\/ddv206","volume":"24","author":"J-W Lim","year":"2015","unstructured":"Lim J-W, Snider L, Yao Z, Tawil R, Van Der Maarel SM, Rigo F, Bennett CF, Filippova GN, Tapscott SJ (2015) DICER\/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD. Hum Mol Genet 24(17):4817\u20134828. https:\/\/doi.org\/10.1093\/hmg\/ddv206","journal-title":"Hum Mol Genet"},{"key":"11_CR131","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DDDT.S97635","volume":"11","author":"KR Lim","year":"2017","unstructured":"Lim KR, Maruyama R, Yokota T (2017) Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther 11:533\u2013545. https:\/\/doi.org\/10.2147\/DDDT.S97635","journal-title":"Drug Des Devel Ther"},{"issue":"28","key":"11_CR132","doi-asserted-by":"publisher","first-page":"16509","DOI":"10.1073\/pnas.1909649117","volume":"117","author":"KRQ Lim","year":"2020","unstructured":"Lim KRQ, Maruyama R, Echigoya Y, Nguyen Q, Zhang A, Khawaja H, Sen Chandra S, Jones T, Jones P, Chen Y-W, Yokota T (2020) Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy. Proc Natl Acad Sci 117(28):16509\u201316515. https:\/\/doi.org\/10.1073\/pnas.1909649117","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"11_CR133","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ymthe.2020.10.010","volume":"29","author":"KRQ Lim","year":"2021","unstructured":"Lim KRQ, Bittel A, Maruyama R, Echigoya Y, Nguyen Q, Huang Y, Dzierlega K, Zhang A, Chen Y-W, Yokota T (2021) DUX4 transcript knockdown with antisense 2\u2032-O-Methoxyethyl Gapmers for the treatment of Facioscapulohumeral muscular dystrophy. Mol Ther 29(2):848\u2013858. https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.010","journal-title":"Mol Ther"},{"issue":"9","key":"11_CR134","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/genes11091109","volume":"11","author":"A L\u00f3pez-Mart\u00ednez","year":"2020","unstructured":"L\u00f3pez-Mart\u00ednez A, Soblechero-Mart\u00edn P et al (2020) An overview of alternative splicing defects implicated in myotonic dystrophy type I. Genes 11(9):1109. https:\/\/doi.org\/10.3390\/genes11091109","journal-title":"Genes"},{"key":"11_CR135","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fneur.2018.00349","volume":"9","author":"M L\u00f3pez-Morat\u00f3","year":"2018","unstructured":"L\u00f3pez-Morat\u00f3 M, Brook JD, Wojciechowska M (2018) Small molecules which improve pathogenesis of myotonic dystrophy type 1. Front Neurol 9:349. https:\/\/doi.org\/10.3389\/fneur.2018.00349","journal-title":"Front Neurol"},{"issue":"1","key":"11_CR136","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5582\/irdr.2019.01016","volume":"8","author":"J Lu","year":"2019","unstructured":"Lu J, Yao Z, Yang Y, Zhang C, Zhang J, Zhang Y (2019) Management strategies in facioscapulohumeral muscular dystrophy. Intractable Rare Dis Res 8(1):9\u201313. https:\/\/doi.org\/10.5582\/irdr.2019.01016","journal-title":"Intractable Rare Dis Res"},{"issue":"5","key":"11_CR137","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/hmg\/4.5.951","volume":"4","author":"PW Lunt","year":"1995","unstructured":"Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 4(5):951\u2013958. https:\/\/doi.org\/10.1093\/hmg\/4.5.951","journal-title":"Hum Mol Genet"},{"key":"11_CR138","doi-asserted-by":"publisher","unstructured":"Mah J, Chen Y-W (2018) A pediatric review of Facioscapulohumeral muscular dystrophy. J Pediatr Neurol 16(04):222\u2013231. https:\/\/doi.org\/10.1055\/s-0037-1604197","DOI":"10.1055\/s-0037-1604197"},{"issue":"6","key":"11_CR139","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1212\/CON.0000000000000404","volume":"22","author":"JK Mah","year":"2016","unstructured":"Mah JK, Joseph JT (2016) An overview of congenital myopathies. Continuum 22(6):1932\u20131953. https:\/\/doi.org\/10.1212\/CON.0000000000000404","journal-title":"Continuum"},{"issue":"15","key":"11_CR140","doi-asserted-by":"publisher","first-page":"e1333","DOI":"10.1212\/WNL.0000000000005297","volume":"90","author":"JK Mah","year":"2018","unstructured":"Mah JK, Feng J, Jacobs MB, Duong T, Carroll K, De Valle K, Carty CL, Morgenroth LP, Guglieri M, Ryan MM, Clemens PR, Thangarajh M, Webster R, Smith E, Connolly AM, McDonald CM, Karachunski P, Tulinius M, Harper A et al (2018) A multinational study on motor function in early-onset FSHD. Neurology 90(15):e1333. https:\/\/doi.org\/10.1212\/WNL.0000000000005297","journal-title":"Neurology"},{"issue":"1","key":"11_CR141","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44178","volume":"5","author":"JK Mah","year":"2022","unstructured":"Mah JK, Clemens PR, Guglieri M, Smith EC, Finkel RS, Tulinius M, Nevo Y, Ryan MM, Webster R, Castro D, Kuntz NL, McDonald CM, Damsker JM, Schwartz BD, Mengle-Gaw LJ, Jackowski S, Stimpson G, Ridout DA, Ayyar-Gupta V et al (2022) Efficacy and safety of Vamorolone in Duchenne muscular dystrophy: a 30-month nonrandomized controlled open-label extension trial. JAMA Netw Open 5(1):e2144178. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.44178","journal-title":"JAMA Netw Open"},{"key":"11_CR142","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.omtn.2018.08.013","volume":"13","author":"J Malcher","year":"2018","unstructured":"Malcher J, Heidt L, Goyenvalle A, Escobar H, Marg A, Beley C, Benchaouir R, Bader M, Spuler S, Garc\u00eda L, Sch\u00f6wel V (2018) Exon skipping in a Dysf-missense mutant mouse model. Mol Ther Nucleic Acids 13:198\u2013207. https:\/\/doi.org\/10.1016\/j.omtn.2018.08.013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"11_CR143","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/hmg\/ddl103","volume":"15","author":"JM Margolis","year":"2006","unstructured":"Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LPW (2006) DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 15(11):1808\u20131815. https:\/\/doi.org\/10.1093\/hmg\/ddl103","journal-title":"Hum Mol Genet"},{"issue":"8","key":"11_CR144","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/hmg\/ddw015","volume":"25","author":"A-C Marsollier","year":"2016","unstructured":"Marsollier A-C, Ciszewski L, Mariot V, Popplewell L, Voit T, Dickson G, Dumonceaux J (2016) Antisense targeting of 3\u2032 end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach. Hum Mol Genet 25(8):1468\u20131478. https:\/\/doi.org\/10.1093\/hmg\/ddw015","journal-title":"Hum Mol Genet"},{"issue":"6","key":"11_CR145","doi-asserted-by":"publisher","first-page":"CD003725","DOI":"10.1002\/14651858.CD003725.pub4","volume":"2016","author":"E Matthews","year":"2016","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (2016) Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev 2016(6):CD003725. https:\/\/doi.org\/10.1002\/14651858.CD003725.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"10119","key":"11_CR146","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","volume":"391","author":"CM McDonald","year":"2018","unstructured":"McDonald CM, Henricson EK, Abresch RT, Duong T, Joyce NC, Hu F, Clemens PR, Hoffman EP, Cnaan A, Gordish-Dressman H, Vishwanathan V, Chidambaranathan S, Biggar WD, McAdam LC, Mah JK, Tulinius M, Cnaan A, Morgenroth LP, Leshner R et al (2018) Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 391(10119):451\u2013461. https:\/\/doi.org\/10.1016\/S0140-6736(17)32160-8","journal-title":"Lancet"},{"issue":"1","key":"11_CR147","doi-asserted-by":"publisher","first-page":"E82","DOI":"10.1152\/ajpendo.00275.2002","volume":"285","author":"CD McMahon","year":"2003","unstructured":"McMahon CD, Popovic L, Oldham JM, Jeanplong F, Smith HK, Kambadur R, Sharma M, Maxwell L, Bass JJ (2003) Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285(1):E82\u2013E87. https:\/\/doi.org\/10.1152\/ajpendo.00275.2002","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"13","key":"11_CR148","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/hrt.2010.214197","volume":"97","author":"EM McNally","year":"2011","unstructured":"McNally EM, Sparano D (2011) Mechanisms and management of the heart in myotonic dystrophy. Heart 97(13):1094\u20131100. https:\/\/doi.org\/10.1136\/hrt.2010.214197","journal-title":"Heart"},{"issue":"4","key":"11_CR149","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/(SICI)1096-8628(20000410)91:4<305::AID-AJMG12>3.0.CO;2-S","volume":"91","author":"EM McNally","year":"2000","unstructured":"McNally EM, Ly CT, Rosenmann H, Mitrani Rosenbaum S, Jiang W, Anderson LV, Soffer D, Argov Z (2000) Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet 91(4):305\u2013312","journal-title":"Am J Med Genet"},{"issue":"12","key":"11_CR150","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1111\/bcp.14884","volume":"87","author":"ML Mellion","year":"2021","unstructured":"Mellion ML, Ronco L, Berends CL, Pagan L, Brooks S, Van Esdonk MJ, Van Brummelen EMJ, Odueyungbo A, Thompson LA, Hage M, Badrising UA, Raines S, Tracewell WG, Van Engelen B, Cadavid D, Groeneveld GJ (2021) Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: safety, tolerability, pharmacokinetics, and target engagement. Br J Clin Pharmacol 87(12):4658\u20134669. https:\/\/doi.org\/10.1111\/bcp.14884","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"11_CR151","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","volume":"1852","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R (2015) Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta (BBA) Mol Basis Dis 1852(4):594\u2013606. https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.019","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"9869","key":"11_CR152","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri E, Muntoni F (2013) Muscular dystrophies. Lancet 381(9869):845\u2013860. https:\/\/doi.org\/10.1016\/S0140-6736(12)61897-2","journal-title":"Lancet"},{"issue":"10213","key":"11_CR153","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, B\u00f6nnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394(10213):2025\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(19)32910-1","journal-title":"Lancet"},{"issue":"2","key":"11_CR154","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/humc.2012.217","volume":"24","author":"F Monjaret","year":"2013","unstructured":"Monjaret F, Suel-Petat L, Bourg-Alibert N, Vihola A, Marchand S, Roudaut C, Gicquel E, Udd B, Richard I, Charton K (2013) The phenotype of Dysferlin-deficient mice is not rescued by adeno-associated virus\u2013mediated transfer of Anoctamin 5. Hum Gene Ther Clin Dev 24(2):65\u201376. https:\/\/doi.org\/10.1089\/humc.2012.217","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"10","key":"11_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026169","volume":"6","author":"C Moorwood","year":"2011","unstructured":"Moorwood C, Lozynska O, Suri N, Napper AD, Diamond SL, Khurana TS (2011) Drug discovery for Duchenne muscular dystrophy via Utrophin promoter activation screening. PLoS One 6(10):e26169. https:\/\/doi.org\/10.1371\/journal.pone.0026169","journal-title":"PLoS One"},{"issue":"15","key":"11_CR156","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/hmg\/ddaa123","volume":"29","author":"F Morales","year":"2020","unstructured":"Morales F, V\u00e1squez M, Corrales E, Vindas-Smith R, Santamar\u00eda-Ulloa C, Zhang B, Sirito M, Estecio MR, Krahe R, Monckton DG (2020) Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset. Hum Mol Genet 29(15):2496\u20132507. https:\/\/doi.org\/10.1093\/hmg\/ddaa123","journal-title":"Hum Mol Genet"},{"issue":"6","key":"11_CR157","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1399-0004.2009.01158.x","volume":"75","author":"M Mostacciuolo","year":"2009","unstructured":"Mostacciuolo M, Pastorello E, Vazza G, Miorin M, Angelini C, Tomelleri G, Galluzzi G, Trevisan C (2009) Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet 75(6):550\u2013555. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01158.x","journal-title":"Clin Genet"},{"issue":"9343","key":"11_CR158","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(02)11397-3","volume":"360","author":"F Muntoni","year":"2002","unstructured":"Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC (2002) Defective glycosylation in muscular dystrophy. Lancet 360(9343):1419\u20131421. https:\/\/doi.org\/10.1016\/S0140-6736(02)11397-3","journal-title":"Lancet"},{"issue":"12","key":"11_CR159","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/acn3.649","volume":"5","author":"BRR Nallamilli","year":"2018","unstructured":"Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, Da Silva C, Beadling R, Alexander JJ, Askree SH, Whitt Z, Bean L, Collins C, Khadilkar S, Gaitonde P, Dastur R, Wicklund M, Mozaffar T, Harms M et al (2018) Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol 5(12):1574\u20131587. https:\/\/doi.org\/10.1002\/acn3.649","journal-title":"Ann Clin Transl Neurol"},{"issue":"16","key":"11_CR160","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1212\/WNL.0000000000000892","volume":"83","author":"P Narayanaswami","year":"2014","unstructured":"Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G, Wicklund M, Barohn RJ, Ensrud E, Griggs RC, Gronseth G, Amato AA (2014) Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development Subcommittee of the American Academy of neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic medicine. Neurology 83(16):1453\u20131463. https:\/\/doi.org\/10.1212\/WNL.0000000000000892","journal-title":"Neurology"},{"issue":"4","key":"11_CR161","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL, Strohl WR (2017) Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31(4):317\u2013334. https:\/\/doi.org\/10.1007\/s40259-017-0234-5","journal-title":"BioDrugs"},{"issue":"1","key":"11_CR163","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/jnnp.74.1.93","volume":"74","author":"DJ Nicholl","year":"2003","unstructured":"Nicholl DJ (2003) The neuromuscular disease center: Www.neuro.wustl.edu\/neuromuscular. J Neurol Neurosurg Psychiatry 74(1):93\u201393. https:\/\/doi.org\/10.1136\/jnnp.74.1.93","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"11_CR164","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.rppneu.2014.03.009","volume":"20","author":"A Nicolini","year":"2014","unstructured":"Nicolini A, Banfi P, Grecchi B, Lax A, Walterspacher S, Barlascini C, Robert D (2014) Non-invasive ventilation in the treatment of sleep-related breathing disorders: a review and update. Rev Port Pneumol 20(6):324\u2013335. https:\/\/doi.org\/10.1016\/j.rppneu.2014.03.009","journal-title":"Rev Port Pneumol"},{"issue":"1","key":"11_CR165","first-page":"1","volume":"33","author":"V Nigro","year":"2014","unstructured":"Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 33(1):1\u201312","journal-title":"Acta Myol"},{"issue":"1","key":"11_CR166","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007798","volume":"6","author":"A Nikolic","year":"2016","unstructured":"Nikolic A, Ricci G, Sera F, Bucci E, Govi M, Mele F, Rossi M, Ruggiero L, Vercelli L, Ravaglia S, Brisca G, Fiorillo C, Villa L, Maggi L, Cao M, D\u2019Amico MC, Siciliano G, Antonini G, Santoro L et al (2016) Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1\u20133 D4Z4 reduced alleles: experience of the FSHD Italian National Registry. BMJ Open 6(1):e007798. https:\/\/doi.org\/10.1136\/bmjopen-2015-007798","journal-title":"BMJ Open"},{"issue":"2","key":"11_CR167","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","volume":"17","author":"EH Niks","year":"2017","unstructured":"Niks EH, Aartsma-Rus A (2017) Exon skipping: a first in class strategy for Duchenne muscular dystrophy. Expert Opin Biol Ther 17(2):225\u2013236. https:\/\/doi.org\/10.1080\/14712598.2017.1271872","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"11_CR168","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/srep02142","volume":"3","author":"K Oana","year":"2013","unstructured":"Oana K, Oma Y, Suo S, Takahashi MP, Nishino I, Takeda S, Ishiura S (2013) Manumycin a corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice. Sci Rep 3(1):2142. https:\/\/doi.org\/10.1038\/srep02142","journal-title":"Sci Rep"},{"issue":"1","key":"11_CR169","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF02766919","volume":"42","author":"K Ohya","year":"1997","unstructured":"Ohya K, Tachi N, Sato T, Kon S, Kikuchi K, Chiba S (1997) Detection of the CTG repeat expansion in congenital myotonic dystrophy. Jpn J Hum Genet 42(1):169\u2013180. https:\/\/doi.org\/10.1007\/BF02766919","journal-title":"Jpn J Hum Genet"},{"issue":"2","key":"11_CR170","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/jpet.119.259663","volume":"370","author":"J Oliva","year":"2019","unstructured":"Oliva J, Galasinski S, Richey A, Campbell AE, Meyers MJ, Modi N, Zhong JW, Tawil R, Tapscott SJ, Sverdrup FM (2019) Clinically advanced p38 inhibitors suppress DUX4 expression in cellular and animal models of Facioscapulohumeral muscular dystrophy. J Pharmacol Exp Ther 370(2):219\u2013230. https:\/\/doi.org\/10.1124\/jpet.119.259663","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"11_CR171","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1212\/01.WNL.0000150584.45055.27","volume":"64","author":"DB Olsen","year":"2005","unstructured":"Olsen DB, Orngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64(6):1064\u20131066. https:\/\/doi.org\/10.1212\/01.WNL.0000150584.45055.27","journal-title":"Neurology"},{"issue":"7","key":"11_CR172","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/bi047992w","volume":"44","author":"C \u00d6stlund","year":"2005","unstructured":"\u00d6stlund C, Garcia-Carrasquillo RM, Belayew A, Worman HJ (2005) Intracellular trafficking and dynamics of double homeodomain proteins. Biochemistry 44(7):2378\u20132384. https:\/\/doi.org\/10.1021\/bi047992w","journal-title":"Biochemistry"},{"key":"11_CR173","unstructured":"Padberg G, Adams C (n.d.) Neurogenetics. Oxford University Press"},{"issue":"1","key":"11_CR174","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pmr.2012.08.017","volume":"24","author":"S Paganoni","year":"2013","unstructured":"Paganoni S, Amato A (2013) Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin N Am 24(1):193\u2013207. https:\/\/doi.org\/10.1016\/j.pmr.2012.08.017","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"10","key":"11_CR175","doi-asserted-by":"publisher","first-page":"e858","DOI":"10.1038\/cddis.2013.385","volume":"4","author":"B Pantic","year":"2013","unstructured":"Pantic B, Trevisan E, Citta A, Rigobello MP, Marin O, Bernardi P, Salvatori S, Rasola A (2013) Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface. Cell Death Dis 4(10):e858\u2013e858. https:\/\/doi.org\/10.1038\/cddis.2013.385","journal-title":"Cell Death Dis"},{"issue":"10","key":"11_CR176","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.3390\/ijms21103694","volume":"21","author":"GK Papadimas","year":"2020","unstructured":"Papadimas GK, Xirou S, Kararizou E, Papadopoulos C (2020) Update on congenital myopathies in adulthood. Int J Mol Sci 21(10):3694. https:\/\/doi.org\/10.3390\/ijms21103694","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11_CR177","doi-asserted-by":"publisher","first-page":"103489","DOI":"10.1016\/j.drudis.2023.103489","volume":"28","author":"M Pascual-Gilabert","year":"2023","unstructured":"Pascual-Gilabert M, Artero R, L\u00f3pez-Castel A (2023) The myotonic dystrophy type 1 drug development pipeline: 2022 edition. Drug Discov Today 28(3):103489. https:\/\/doi.org\/10.1016\/j.drudis.2023.103489","journal-title":"Drug Discov Today"},{"key":"11_CR178","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","volume":"81","author":"E Passerieux","year":"2015","unstructured":"Passerieux E, Hayot M, Jaussent A, Carnac G, Gouzi F, Pillard F, Picot M-C, B\u00f6cker K, Hugon G, Pincemail J, Defraigne JO, Verrips T, Mercier J, Laoudj-Chenivesse D (2015) Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial. Free Radic Biol Med 81:158\u2013169. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.09.014","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"11_CR179","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/s41598-019-47818-w","volume":"9","author":"RS Pearsall","year":"2019","unstructured":"Pearsall RS, Davies MV, Cannell M, Li J, Widrick J, Mulivor AW, Wallner S, Troy ME, Spaits M, Liharska K, Sako D, Castonguay R, Keates S, Grinberg AV, Suragani RNVS, Kumar R (2019) Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. Sci Rep 9(1):11392. https:\/\/doi.org\/10.1038\/s41598-019-47818-w","journal-title":"Sci Rep"},{"issue":"1","key":"11_CR180","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1078\/0344-0338-00004","volume":"197","author":"J Pe\u00f1a","year":"2001","unstructured":"Pe\u00f1a J, Luque E, Noguera F, Jimena I, Vaamonde R (2001) Experimental induction of ring fibers in regenerating skeletal muscle. Pathol Res Pract 197(1):21\u201327. https:\/\/doi.org\/10.1078\/0344-0338-00004","journal-title":"Pathol Res Pract"},{"key":"11_CR181","unstructured":"Pestronk A (2016) Myotonic Dystorphy. https:\/\/neuromuscular.wustl.edu\/pathol\/myotdyspath.htm"},{"issue":"4","key":"11_CR182","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/nar\/gkv029","volume":"43","author":"OJ Pettersson","year":"2015","unstructured":"Pettersson OJ, Aagaard L, Jensen TG, Damgaard CK (2015) Molecular mechanisms in DM1 \u2212 a focus on foci. Nucleic Acids Res 43(4):2433\u20132441. https:\/\/doi.org\/10.1093\/nar\/gkv029","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"11_CR183","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mus.21122","volume":"38","author":"V Pisani","year":"2008","unstructured":"Pisani V, Panico MB, Terracciano C, Bonifazi E, Meola G, Novelli G, Bernardi G, Angelini C, Massa R (2008) Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2. Muscle Nerve 38(5):1405\u20131411. https:\/\/doi.org\/10.1002\/mus.21122","journal-title":"Muscle Nerve"},{"issue":"5","key":"11_CR184","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2217\/nmt-2020-0066","volume":"11","author":"E Pozsgai","year":"2021","unstructured":"Pozsgai E, Griffin D, Potter R, Sahenk Z, Lehman K, Rodino-Klapac LR, Mendell JR (2021) Unmet needs and evolving treatment for limb girdle muscular dystrophies. Neurodegener Dis Manag 11(5):411\u2013429. https:\/\/doi.org\/10.2217\/nmt-2020-0066","journal-title":"Neurodegener Dis Manag"},{"issue":"4","key":"11_CR185","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/ajmg.a.36950","volume":"167","author":"A Pratte","year":"2015","unstructured":"Pratte A, Pr\u00e9vost C, Puymirat J, Mathieu J (2015) Anticipation in myotonic dystrophy type 1 parents with small CTG expansions. Am J Med Genet A 167(4):708\u2013714. https:\/\/doi.org\/10.1002\/ajmg.a.36950","journal-title":"Am J Med Genet A"},{"issue":"24","key":"11_CR186","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1111\/febs.13098","volume":"281","author":"I Ramirez-Sanchez","year":"2014","unstructured":"Ramirez-Sanchez I, De Los Santos S, Gonzalez-Basurto S, Canto P, Mendoza-Lorenzo P, Palma-Flores C, Ceballos-Reyes G, Villarreal F, Zentella-Dehesa A, Coral-Vazquez R (2014) (\u2212)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic \u03b4-sarcoglycan null mouse striated muscle. FEBS J 281(24):5567\u20135580. https:\/\/doi.org\/10.1111\/febs.13098","journal-title":"FEBS J"},{"issue":"3","key":"11_CR187","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","volume":"27","author":"JN Ramos","year":"2019","unstructured":"Ramos JN, Hollinger K, Bengtsson NE, Allen JM, Hauschka SD, Chamberlain JS (2019) Development of novel micro-dystrophins with enhanced functionality. Mol Ther 27(3):623\u2013635. https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.002","journal-title":"Mol Ther"},{"issue":"2","key":"11_CR188","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/adc.68.2.177","volume":"68","author":"W Reardon","year":"1993","unstructured":"Reardon W, Newcombe R, Fenton I, Sibert J, Harper PS (1993) The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child 68(2):177\u2013181. https:\/\/doi.org\/10.1136\/adc.68.2.177","journal-title":"Arch Dis Child"},{"issue":"11","key":"11_CR189","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","volume":"136","author":"G Ricci","year":"2013","unstructured":"Ricci G, Scionti I, Sera F, Govi M, D\u2019Amico R, Frambolli I, Mele F, Filosto M, Vercelli L, Ruggiero L, Berardinelli A, Angelini C, Antonini G, Bucci E, Cao M, Daolio J, Di Muzio A, Di Leo R, Galluzzi G et al (2013) Large scale genotype\u2013phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain 136(11):3408\u20133417. https:\/\/doi.org\/10.1093\/brain\/awt226","journal-title":"Brain"},{"issue":"7","key":"11_CR190","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/archneur.1977.00500190042006","volume":"34","author":"SP Ringel","year":"1977","unstructured":"Ringel SP, Carroll JE, Schold SC (1977) The spectrum of mild X-linked recessive muscular dystrophy. Arch Neurol 34(7):408\u2013416. https:\/\/doi.org\/10.1001\/archneur.1977.00500190042006","journal-title":"Arch Neurol"},{"issue":"5","key":"11_CR191","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.ajpath.2011.07.022","volume":"179","author":"K Rouger","year":"2011","unstructured":"Rouger K, Larcher T, Dubreil L, Deschamps J-Y, Le Guiner C, Jouvion G, Delorme B, Lieubeau B, Carlus M, Fornasari B, Theret M, Orlando P, Ledevin M, Zuber C, Leroux I, Deleau S, Guigand L, Testault I, Le Rumeur E et al (2011) Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in Duchenne muscular dystrophy dogs. Am J Pathol 179(5):2501\u20132518. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.022","journal-title":"Am J Pathol"},{"issue":"4","key":"11_CR192","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nmd.2020.02.015","volume":"30","author":"M-P Roussel","year":"2020","unstructured":"Roussel M-P, H\u00e9bert LJ, Duchesne E (2020) Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1. Neuromuscul Disord 30(4):283\u2013293. https:\/\/doi.org\/10.1016\/j.nmd.2020.02.015","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"11_CR193","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000213303","volume":"38","author":"K Sahashi","year":"1992","unstructured":"Sahashi K, Tanaka M, Tashiro M, Ohno K, Ibi T, Takahashi A, Ozawa T (1992) Increased mitochondrial DNA deletions in the skeletal muscle of myotonic dystrophy. Gerontology 38(1\u20132):18\u201329. https:\/\/doi.org\/10.1159\/000213303","journal-title":"Gerontology"},{"key":"11_CR194","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409001203","volume":"11","author":"D Sandon\u00e0","year":"2009","unstructured":"Sandon\u00e0 D, Betto R (2009) Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med 11:e28. https:\/\/doi.org\/10.1017\/S1462399409001203","journal-title":"Expert Rev Mol Med"},{"issue":"2","key":"11_CR195","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ijcard.2012.11.076","volume":"168","author":"VA Sansone","year":"2013","unstructured":"Sansone VA, Brigonzi E, Schoser B, Villani S, Gaeta M, De Ambroggi G, Bandera F, De Ambroggi L, Meola G (2013) The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes. Int J Cardiol 168(2):1147\u20131153. https:\/\/doi.org\/10.1016\/j.ijcard.2012.11.076","journal-title":"Int J Cardiol"},{"key":"11_CR196","unstructured":"Santhera (n.d.) Our Pipeline: Vamorolone. Santhera. https:\/\/www.santhera.com\/health-care-professionals\/vamorolone"},{"issue":"2","key":"11_CR197","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.spen.2006.06.003","volume":"13","author":"J Schessl","year":"2006","unstructured":"Schessl J, Zou Y, B\u00f6nnemann CG (2006) Congenital muscular dystrophies and the extracellular matrix. Semin Pediatr Neurol 13(2):80\u201389. https:\/\/doi.org\/10.1016\/j.spen.2006.06.003","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"11_CR198","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4088\/PCC.07r00545","volume":"11","author":"JRL Schwartz","year":"2009","unstructured":"Schwartz JRL, Roth T, Hirshkowitz M, Wright KP (2009) Recognition and management of excessive sleepiness in the primary care setting. Prim Care Companion J Clin Psychiatry 11(5):197\u2013204. https:\/\/doi.org\/10.4088\/PCC.07r00545","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"2","key":"11_CR199","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10974-019-09519-9","volume":"40","author":"CA Sewry","year":"2019","unstructured":"Sewry CA, Laitila JM, Wallgren-Pettersson C (2019) Nemaline myopathies: a current view. J Muscle Res Cell Motil 40(2):111\u2013126. https:\/\/doi.org\/10.1007\/s10974-019-09519-9","journal-title":"J Muscle Res Cell Motil"},{"issue":"3","key":"11_CR200","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006658","volume":"13","author":"SC Shadle","year":"2017","unstructured":"Shadle SC, Zhong JW, Campbell AE, Conerly ML, Jagannathan S, Wong C-J, Morello TD, Van Der Maarel SM, Tapscott SJ (2017) DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet 13(3):e1006658. https:\/\/doi.org\/10.1371\/journal.pgen.1006658","journal-title":"PLoS Genet"},{"issue":"5","key":"11_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064691","volume":"8","author":"V Sharma","year":"2013","unstructured":"Sharma V, Harafuji N, Belayew A, Chen Y-W (2013) DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One 8(5):e64691. https:\/\/doi.org\/10.1371\/journal.pone.0064691","journal-title":"PLoS One"},{"issue":"2","key":"11_CR202","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/genes13020367","volume":"13","author":"P Soltanzadeh","year":"2022","unstructured":"Soltanzadeh P (2022) Myotonic dystrophies: a genetic overview. Genes 13(2):367. https:\/\/doi.org\/10.3390\/genes13020367","journal-title":"Genes"},{"key":"11_CR203","doi-asserted-by":"publisher","first-page":"1235589","DOI":"10.3389\/fgene.2023.1235589","volume":"14","author":"C Strafella","year":"2023","unstructured":"Strafella C, Caputo V, Bortolani S, Torchia E, Megalizzi D, Trastulli G, Monforte M, Colantoni L, Caltagirone C, Ricci E, Tasca G, Cascella R, Giardina E (2023) Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD. Front Genet 14:1235589. https:\/\/doi.org\/10.3389\/fgene.2023.1235589","journal-title":"Front Genet"},{"issue":"8","key":"11_CR204","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","volume":"28","author":"V Straub","year":"2018","unstructured":"Straub V, Murphy A, Udd B, Corrado A, Aym\u00e9 S, B\u00f6nneman C, De Visser M, Hamosh A, Jacobs L, Khizanishvili N, Kroneman M, Laflor\u00eat P, Murphy A, Nigro V, Rufibach L, Sarkozy A, Swanepoel S, Torrente I, Udd B et al (2018) 229th ENMC international workshop: limb girdle muscular dystrophies \u2013 nomenclature and reformed classification Naarden, The Netherlands, 17\u201319 march 2017. Neuromuscul Disord 28(8):702\u2013710. https:\/\/doi.org\/10.1016\/j.nmd.2018.05.007","journal-title":"Neuromuscul Disord"},{"key":"11_CR205","volume-title":"Muscular dystrophy and spinal muscular atrophy. Physical therapy for children","author":"W Stuberg","year":"2006","unstructured":"Stuberg W (2006) Muscular dystrophy and spinal muscular atrophy. Physical therapy for children. Saunders Elsevier"},{"issue":"1","key":"11_CR206","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13023-021-01862-w","volume":"16","author":"SM Szabo","year":"2021","unstructured":"Szabo SM, Salhany RM, Deighton A, Harwood M, Mah J, Gooch KL (2021) The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review. Orphanet J Rare Dis 16(1):237. https:\/\/doi.org\/10.1186\/s13023-021-01862-w","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"11_CR207","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-012-1024-2","volume":"125","author":"H Tajsharghi","year":"2013","unstructured":"Tajsharghi H, Oldfors A (2013) Myosinopathies: pathology and mechanisms. Acta Neuropathol 125(1):3\u201318. https:\/\/doi.org\/10.1007\/s00401-012-1024-2","journal-title":"Acta Neuropathol"},{"issue":"7","key":"11_CR208","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1017\/S1047951121004674","volume":"32","author":"K Takamizawa","year":"2022","unstructured":"Takamizawa K, Kim K-S, Ueda H (2022) Emery-Dreifuss muscular dystrophy with dilated cardiomyopathy preceding skeletal muscle symptoms. Cardiol Young 32(7):1175\u20131177. https:\/\/doi.org\/10.1017\/S1047951121004674","journal-title":"Cardiol Young"},{"issue":"1","key":"11_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.20522","volume":"34","author":"R Tawil","year":"2006","unstructured":"Tawil R, Van Der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 34(1):1\u201315. https:\/\/doi.org\/10.1002\/mus.20522","journal-title":"Muscle Nerve"},{"issue":"1","key":"11_CR210","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.48.1.46","volume":"48","author":"R Tawil","year":"1997","unstructured":"Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC (1997) A pilot trial of prednisone in Facioscapulohumeral muscular dystrophy. Neurology 48(1):46\u201349. https:\/\/doi.org\/10.1212\/WNL.48.1.46","journal-title":"Neurology"},{"issue":"4","key":"11_CR211","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"R Tawil","year":"2015","unstructured":"Tawil R, Kissel JT, Heatwole C, Pandya S, Gronseth G, Benatar M (2015) Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic medicine. Neurology 85(4):357\u2013364. https:\/\/doi.org\/10.1212\/WNL.0000000000001783","journal-title":"Neurology"},{"issue":"3","key":"11_CR212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091221","volume":"9","author":"RL Terry","year":"2014","unstructured":"Terry RL, Kaneb HM, Wells DJ (2014) Poloxomer 188 has a deleterious effect on dystrophic skeletal muscle function. PLoS One 9(3):e91221. https:\/\/doi.org\/10.1371\/journal.pone.0091221","journal-title":"PLoS One"},{"key":"11_CR213","doi-asserted-by":"publisher","unstructured":"Teveroni E, Pellegrino M, Sacconi S, Calandra P, Cascino I, Farioli-Vecchioli S, Puma A, Garibaldi M, Morosetti R, Tasca G, Ricci E, Trevisan CP, Galluzzi G, Pontecorvi A, Crescenzi M, Deidda G, Moretti F (2017) Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity. J Clin Invest 127(4):1531\u20131545. https:\/\/doi.org\/10.1172\/JCI89401","DOI":"10.1172\/JCI89401"},{"issue":"5","key":"11_CR214","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nrneurol.2016.35","volume":"12","author":"R Thompson","year":"2016","unstructured":"Thompson R, Straub V (2016) Limb-girdle muscular dystrophies \u2013 international collaborations for translational research. Nat Rev Neurol 12(5):294\u2013309. https:\/\/doi.org\/10.1038\/nrneurol.2016.35","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"11_CR215","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/s41467-022-29473-4","volume":"13","author":"H Tokuoka","year":"2022","unstructured":"Tokuoka H, Imae R, Nakashima H, Manya H, Masuda C, Hoshino S, Kobayashi K, Lefeber DJ, Matsumoto R, Okada T, Endo T, Kanagawa M, Toda T (2022) CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model. Nat Commun 13(1):1847. https:\/\/doi.org\/10.1038\/s41467-022-29473-4","journal-title":"Nat Commun"},{"issue":"1","key":"11_CR216","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nmd.2003.07.001","volume":"14","author":"MMO Tonini","year":"2004","unstructured":"Tonini MMO, Passos-Bueno MR, Cerqueira A, Matioli SR, Pavanello R, Zatz M (2004) Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 14(1):33\u201338. https:\/\/doi.org\/10.1016\/j.nmd.2003.07.001","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"11_CR217","doi-asserted-by":"publisher","first-page":"CD004762","DOI":"10.1002\/14651858.CD004762.pub2","volume":"2011","author":"J Trip","year":"2006","unstructured":"Trip J, Drost GG, Van Engelen BG, Faber CG (2006) Drug treatment for myotonia. Cochrane Database Syst Rev 2011(6):CD004762. https:\/\/doi.org\/10.1002\/14651858.CD004762.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"11_CR218","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.freeradbiomed.2012.06.041","volume":"53","author":"A Turki","year":"2012","unstructured":"Turki A, Hayot M, Carnac G, Pillard F, Passerieux E, Bommart S, de Mauverger ER, Hugon G, Pincemail J, Pietri S, Lambert K, Belayew A, Vassetzky Y, Juntas Morales R, Mercier J, Laoudj-Chenivesse D (2012) Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med 53(5):1068\u20131079. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.06.041","journal-title":"Free Radic Biol Med"},{"key":"11_CR219","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-90-481-2813-6_3","volume-title":"Inherited neuromuscular diseases","author":"B Udd","year":"2009","unstructured":"Udd B (2009) Genetics and pathogenesis of distal muscular dystrophies. In: Espin\u00f3s C, Felipo V, Palau F (eds) Inherited neuromuscular diseases, vol 652. Springer, New York, pp 23\u201338. https:\/\/doi.org\/10.1007\/978-90-481-2813-6_3"},{"issue":"1","key":"11_CR220","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nmd.2011.10.003","volume":"22","author":"B Udd","year":"2012","unstructured":"Udd B (2012) Distal myopathies \u2013 new genetic entities expand diagnostic challenge. Neuromuscul Disord 22(1):5\u201312. https:\/\/doi.org\/10.1016\/j.nmd.2011.10.003","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"11_CR221","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/ncomms2964","volume":"4","author":"A Urciuolo","year":"2013","unstructured":"Urciuolo A, Quarta M, Morbidoni V, Gattazzo F, Molon S, Grumati P, Montemurro F, Tedesco FS, Blaauw B, Cossu G, Vozzi G, Rando TA, Bonaldo P (2013) Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat Commun 4(1):1964. https:\/\/doi.org\/10.1038\/ncomms2964","journal-title":"Nat Commun"},{"issue":"6","key":"11_CR222","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1083\/jcb.134.6.1483","volume":"134","author":"PH Vachon","year":"1996","unstructured":"Vachon PH, Loechel F, Xu H, Wewer UM, Engvall E (1996) Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J Cell Biol 134(6):1483\u20131497. https:\/\/doi.org\/10.1083\/jcb.134.6.1483","journal-title":"J Cell Biol"},{"issue":"5","key":"11_CR223","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML van den Boogaard","year":"2016","unstructured":"van den Boogaard ML, Lemmers RJLF, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, van der Vliet PJ, Straasheijm KR, van den Akker RFP, Kriek M, Laurense-Bik MEY, Raz V, van Ostaijen-ten Dam MM, Hansson KBM, van der Kooi EL, Kiuru-Enari S, Udd B, van Tol MJD, Nishino I et al (2016) Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of Facioscapulohumeral dystrophy. Am J Hum Genet 98(5):1020\u20131029. https:\/\/doi.org\/10.1016\/j.ajhg.2016.03.013","journal-title":"Am J Hum Genet"},{"issue":"4","key":"11_CR224","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1212\/01.WNL.0000134660.30793.1F","volume":"63","author":"EL van der Kooi","year":"2004","unstructured":"van der Kooi EL, Vogels OJM, van Asseldonk RJGP, Lindeman E, Hendriks JCM, Wohlgemuth M, van der Maarel SM, Padberg GW (2004) Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 63(4):702\u2013708. https:\/\/doi.org\/10.1212\/01.WNL.0000134660.30793.1F","journal-title":"Neurology"},{"issue":"2","key":"11_CR225","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbadis.2006.05.009","volume":"1772","author":"SM Van Der Maarel","year":"2007","unstructured":"Van Der Maarel SM, Frants RR, Padberg GW (2007) Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta (BBA) Mol Basis Dis 1772(2):186\u2013194. https:\/\/doi.org\/10.1016\/j.bbadis.2006.05.009","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"4","key":"11_CR226","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PGM Van Overveld","year":"2003","unstructured":"Van Overveld PGM, Lemmers RJFL, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, Van Ommen G-JB, Frants RR, Van Der Maarel SM (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 35(4):315\u2013317. https:\/\/doi.org\/10.1038\/ng1262","journal-title":"Nat Genet"},{"issue":"10","key":"11_CR227","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026820","volume":"6","author":"C Vanderplanck","year":"2011","unstructured":"Vanderplanck C, Ansseau E, Charron S, Stricwant N, Tassin A, Laoudj-Chenivesse D, Wilton SD, Copp\u00e9e F, Belayew A (2011) The FSHD atrophic Myotube phenotype is caused by DUX4 expression. PLoS One 6(10):e26820. https:\/\/doi.org\/10.1371\/journal.pone.0026820","journal-title":"PLoS One"},{"issue":"11","key":"11_CR228","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1212\/01.WNL.0000065898.61358.09","volume":"60","author":"A Vihola","year":"2003","unstructured":"Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforet P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM\/DM2. Neurology 60(11):1854\u20131857. https:\/\/doi.org\/10.1212\/01.WNL.0000065898.61358.09","journal-title":"Neurology"},{"issue":"4","key":"11_CR229","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2990.2012.01289.x","volume":"39","author":"A Vihola","year":"2013","unstructured":"Vihola A, Sirito M, Bachinski LL, Raheem O, Screen M, Suominen T, Krahe R, Udd B (2013) Altered expression and splicing of Ca2+ metabolism genes in myotonic dystrophies DM1 and DM2: altered expression of Ca2+ genes in DM. Neuropathol Appl Neurobiol 39(4):390\u2013405. https:\/\/doi.org\/10.1111\/j.1365-2990.2012.01289.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"11_CR230","volume-title":"Myotonic dystrophy","author":"D Vydra","year":"2023","unstructured":"Vydra D, Rayi A (2023) Myotonic dystrophy. StatPearls Publishing"},{"issue":"5","key":"11_CR231","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.21338","volume":"63","author":"KR Wagner","year":"2008","unstructured":"Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T et al (2008) A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63(5):561\u2013571. https:\/\/doi.org\/10.1002\/ana.21338","journal-title":"Ann Neurol"},{"issue":"7","key":"11_CR232","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/mt.2012.68","volume":"20","author":"LM Wallace","year":"2012","unstructured":"Wallace LM, Liu J, Domire JS, Garwick-Coppens SE, Guckes SM, Mendell JR, Flanigan KM, Harper SQ (2012) RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy. Mol Ther 20(7):1417\u20131423. https:\/\/doi.org\/10.1038\/mt.2012.68","journal-title":"Mol Ther"},{"issue":"1","key":"11_CR233","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1172-8-26","volume":"8","author":"MC Walter","year":"2013","unstructured":"Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, M\u00fcller-Reible C, Vorgerd M, Urban P, Schrank B, Deschauer M, Schlotter-Weigel B, Kohnen R, Lochm\u00fcller H (2013) Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis 8(1):26. https:\/\/doi.org\/10.1186\/1750-1172-8-26","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"11_CR234","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/brain\/77.2.169","volume":"77","author":"JN Walton","year":"1954","unstructured":"Walton JN, Nattrass FJ (1954) On the classification, natural history and treatment of the myopathies. Brain 77(2):169\u2013231. https:\/\/doi.org\/10.1093\/brain\/77.2.169","journal-title":"Brain"},{"issue":"25","key":"11_CR235","doi-asserted-by":"publisher","first-page":"13714","DOI":"10.1073\/pnas.240335297","volume":"97","author":"B Wang","year":"2000","unstructured":"Wang B, Li J, Xiao X (2000) Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci 97(25):13714\u201313719. https:\/\/doi.org\/10.1073\/pnas.240335297","journal-title":"Proc Natl Acad Sci"},{"key":"11_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.810180","volume":"10","author":"H Wang","year":"2022","unstructured":"Wang H, Wang L, Zhong B, Dai Z (2022) Protein splicing of inteins: a powerful tool in synthetic biology. Front Bioeng Biotechnol 10:810180. https:\/\/doi.org\/10.3389\/fbioe.2022.810180","journal-title":"Front Bioeng Biotechnol"},{"key":"11_CR237","unstructured":"Weeden T, Spring S (2020) Methods of preparing protein-oligonucleotide complexes (Patent WO2020247738A1)"},{"key":"11_CR238","unstructured":"Weekly Steroids in Muscular Dystrophy (WSiMD) (2023) Full text. View-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT04054375"},{"issue":"1","key":"11_CR239","doi-asserted-by":"publisher","DOI":"10.4161\/rdis.26555","volume":"1","author":"C Wei","year":"2013","unstructured":"Wei C, Jones K, Timchenko NA, Timchenko L (2013) GSK3\u03b2 is a new therapeutic target for myotonic dystrophy type 1. Rare Diseases 1(1):e26555. https:\/\/doi.org\/10.4161\/rdis.26555","journal-title":"Rare Diseases"},{"key":"11_CR240","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fneur.2018.00303","volume":"9","author":"S Wenninger","year":"2018","unstructured":"Wenninger S, Montagnese F, Schoser B (2018) Core clinical phenotypes in myotonic dystrophies. Front Neurol 9:303. https:\/\/doi.org\/10.3389\/fneur.2018.00303","journal-title":"Front Neurol"},{"key":"11_CR241","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.omtm.2023.08.013","volume":"30","author":"H Wilton-Clark","year":"2023","unstructured":"Wilton-Clark H, Yokota T (2023) CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy. Mol Ther Methods Clin Dev 30:500\u2013501. https:\/\/doi.org\/10.1016\/j.omtm.2023.08.013","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"22","key":"11_CR242","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1093\/hmg\/ddg327","volume":"12","author":"ST Winokur","year":"2003","unstructured":"Winokur ST (2003) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 12(22):2895\u20132907. https:\/\/doi.org\/10.1093\/hmg\/ddg327","journal-title":"Hum Mol Genet"},{"issue":"10","key":"11_CR243","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1210\/clinem\/dgab430","volume":"106","author":"SJ Winters","year":"2021","unstructured":"Winters SJ (2021) Endocrine dysfunction in patients with myotonic dystrophy. J Clin Endocrinol Metabol 106(10):2819\u20132827. https:\/\/doi.org\/10.1210\/clinem\/dgab430","journal-title":"J Clin Endocrinol Metabol"},{"issue":"6","key":"11_CR244","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/cpt.2747","volume":"112","author":"J Wojciechowski","year":"2022","unstructured":"Wojciechowski J, Purohit VS, Harnisch LO, Dua P, Tan B, Nicholas T (2022) Population PK and PD analysis of Domagrozumab in pediatric patients with Duchenne muscular dystrophy. Clin Pharmacol Ther 112(6):1291\u20131302. https:\/\/doi.org\/10.1002\/cpt.2747","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"11_CR245","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1038\/s41598-018-25204-2","volume":"8","author":"M Yanaizu","year":"2018","unstructured":"Yanaizu M, Sakai K, Tosaki Y, Kino Y, Satoh J (2018) Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation. Sci Rep 8(1):6937. https:\/\/doi.org\/10.1038\/s41598-018-25204-2","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"11_CR246","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0014-5793(03)00110-8","volume":"537","author":"DJ Yip","year":"2003","unstructured":"Yip DJ, Picketts DJ (2003) Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation. FEBS Lett 537(1\u20133):133\u2013138. https:\/\/doi.org\/10.1016\/S0014-5793(03)00110-8","journal-title":"FEBS Lett"},{"issue":"7","key":"11_CR247","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.stemcr.2022.06.002","volume":"17","author":"M Yoshihara","year":"2022","unstructured":"Yoshihara M, Kirjanov I, Nyk\u00e4nen S, Sokka J, Weltner J, Lundin K, Gawriyski L, Jouhilahti E-M, Varjosalo M, Tervaniemi MH, Otonkoski T, Trokovic R, Katayama S, Vuoristo S, Kere J (2022) Transient DUX4 expression in human embryonic stem cells induces blastomere-like expression program that is marked by SLC34A2. Stem Cell Reports 17(7):1743\u20131756. https:\/\/doi.org\/10.1016\/j.stemcr.2022.06.002","journal-title":"Stem Cell Reports"},{"issue":"11","key":"11_CR248","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.amjcard.2012.01.392","volume":"109","author":"G Yoskovitz","year":"2012","unstructured":"Yoskovitz G, Peled Y, Gramlich M, Lahat H, Resnik-Wolf H, Feinberg MS, Afek A, Pras E, Arad M, Gerull B, Freimark D (2012) A novel Titin mutation in adult-onset familial dilated cardiomyopathy. Am J Cardiol 109(11):1644\u20131650. https:\/\/doi.org\/10.1016\/j.amjcard.2012.01.392","journal-title":"Am J Cardiol"},{"issue":"4","key":"11_CR249","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young CS, Hicks MR, Ermolova NV, Nakano H, Jan M, Younesi S, Karumbayaram S, Kumagai-Cresse C, Wang D, Zack JA, Kohn DB, Nakano A, Nelson SF, Miceli MC, Spencer MJ, Pyle AD (2016) A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18(4):533\u2013540. https:\/\/doi.org\/10.1016\/j.stem.2016.01.021","journal-title":"Cell Stem Cell"},{"key":"11_CR250","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gde.2017.01.007","volume":"44","author":"K Yum","year":"2017","unstructured":"Yum K, Wang ET, Kalsotra A (2017) Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. Curr Opin Genet Dev 44:30\u201337. https:\/\/doi.org\/10.1016\/j.gde.2017.01.007","journal-title":"Curr Opin Genet Dev"},{"issue":"2","key":"11_CR251","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","volume":"77","author":"M Zatz","year":"1998","unstructured":"Zatz M, Marie SK, Cerqueira A, Vainzof M, Pavanello RC, Passos-Bueno MR (1998) The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet 77(2):155\u2013161","journal-title":"Am J Med Genet"},{"issue":"1","key":"11_CR252","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1073\/pnas.1013343108","volume":"108","author":"T Zu","year":"2011","unstructured":"Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MAC, Nan Z, Forster C, Low WC, Schoser B, Somia NV, Clark HB, Schmechel S, Bitterman PB, Gourdon G et al (2011) Non-ATG\u2013initiated translation directed by microsatellite expansions. Proc Natl Acad Sci 108(1):260\u2013265. https:\/\/doi.org\/10.1073\/pnas.1013343108","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"11_CR253","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuron.2017.08.039","volume":"95","author":"T Zu","year":"2017","unstructured":"Zu T, Cleary JD, Liu Y, Ba\u00f1ez-Coronel M, Bubenik JL, Ayhan F, Ashizawa T, Xia G, Clark HB, Yachnis AT, Swanson MS, Ranum LPW (2017) RAN translation regulated by Muscleblind proteins in myotonic dystrophy type 2. Neuron 95(6):1292\u20131305.e5. https:\/\/doi.org\/10.1016\/j.neuron.2017.08.039","journal-title":"Neuron"},{"issue":"2","key":"11_CR254","doi-asserted-by":"publisher","first-page":"101","DOI":"10.14670\/HH-18-403","volume":"37","author":"M Zweyer","year":"2022","unstructured":"Zweyer M, Sabir H, Dowling P, Gargan S, Murphy S, Swandulla D, Ohlendieck K (2022) Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers. Histol Histopathol 37(2):101\u2013116. https:\/\/doi.org\/10.14670\/HH-18-403","journal-title":"Histol Histopathol"}],"container-title":["Advances in Experimental Medicine and Biology","The Skeletal Muscle: Plasticity, Degeneration and Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-88361-3_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:13:40Z","timestamp":1785521620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-88361-3_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031883606","9783031883613"],"references-count":253,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-88361-3_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"30 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}